<?xml version="1.0" encoding="UTF-8"  standalone="no" ?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1986-07-21" modified="2023-09-13" version="257" xmlns="http://uniprot.org/uniprot">
  <accession>P02788</accession>
  <accession>A8K9U8</accession>
  <accession>B2MV13</accession>
  <accession>B7Z4X2</accession>
  <accession>E7EQH5</accession>
  <accession>O00756</accession>
  <accession>Q16780</accession>
  <accession>Q16785</accession>
  <accession>Q16786</accession>
  <accession>Q16789</accession>
  <accession>Q5DSM0</accession>
  <accession>Q8IU92</accession>
  <accession>Q8IZH6</accession>
  <accession>Q8TCD2</accession>
  <accession>Q96KZ4</accession>
  <accession>Q96KZ5</accession>
  <accession>Q9H1Z3</accession>
  <accession>Q9UCY5</accession>
  <name>TRFL_HUMAN</name>
  <protein>
    <recommendedName>
      <fullName>Lactotransferrin</fullName>
      <shortName>Lactoferrin</shortName>
      <ecNumber evidence="12">3.4.21.-</ecNumber>
    </recommendedName>
    <alternativeName>
      <fullName>Growth-inhibiting protein 12</fullName>
    </alternativeName>
    <alternativeName>
      <fullName>Talalactoferrin</fullName>
    </alternativeName>
    <component>
      <recommendedName>
        <fullName>Lactoferricin-H</fullName>
        <shortName>Lfcin-H</shortName>
      </recommendedName>
    </component>
    <component>
      <recommendedName>
        <fullName>Kaliocin-1</fullName>
      </recommendedName>
    </component>
    <component>
      <recommendedName>
        <fullName>Lactoferroxin-A</fullName>
      </recommendedName>
    </component>
    <component>
      <recommendedName>
        <fullName>Lactoferroxin-B</fullName>
      </recommendedName>
    </component>
    <component>
      <recommendedName>
        <fullName>Lactoferroxin-C</fullName>
      </recommendedName>
    </component>
  </protein>
  <gene>
    <name type="primary">LTF</name>
    <name type="synonym">GIG12</name>
    <name type="synonym">LF</name>
  </gene>
  <organism>
    <name type="scientific">Homo sapiens</name>
    <name type="common">Human</name>
    <dbReference type="NCBI Taxonomy" id="9606"/>
    <lineage>
      <taxon>Eukaryota</taxon>
      <taxon>Metazoa</taxon>
      <taxon>Chordata</taxon>
      <taxon>Craniata</taxon>
      <taxon>Vertebrata</taxon>
      <taxon>Euteleostomi</taxon>
      <taxon>Mammalia</taxon>
      <taxon>Eutheria</taxon>
      <taxon>Euarchontoglires</taxon>
      <taxon>Primates</taxon>
      <taxon>Haplorrhini</taxon>
      <taxon>Catarrhini</taxon>
      <taxon>Hominidae</taxon>
      <taxon>Homo</taxon>
    </lineage>
  </organism>
  <reference key="1">
    <citation type="journal article" date="1990" name="Nucleic Acids Res." volume="18" first="5288" last="5288">
      <title>Complete nucleotide sequence of human mammary gland lactoferrin.</title>
      <authorList>
        <person name="Rey M.W."/>
        <person name="Woloshuk S.L."/>
        <person name="de Boer H.A."/>
        <person name="Pieper F.R."/>
      </authorList>
      <dbReference type="PubMed" id="2402455"/>
      <dbReference type="DOI" id="10.1093/nar/18.17.5288"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
    <scope>VARIANTS ARG-22 INS; THR-148 AND CYS-422</scope>
    <source>
      <tissue>Mammary gland</tissue>
    </source>
  </reference>
  <reference key="2">
    <citation type="thesis" date="1994" institute="Genetic Engineering Research Institute" country="South Korea">
      <title>Cloning of human lactoferrin gene and its polymorphism in normal and cancer cells.</title>
      <authorList>
        <person name="Cho Y.Y."/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
    <scope>VARIANT ARG-22 INS</scope>
    <source>
      <tissue>Mammary gland</tissue>
    </source>
  </reference>
  <reference key="3">
    <citation type="journal article" date="1997" name="Proc. Natl. Acad. Sci. U.S.A." volume="94" first="2198" last="2203">
      <title>Identification of an alternative form of human lactoferrin mRNA that is expressed differentially in normal tissues and tumor-derived cell lines.</title>
      <authorList>
        <person name="Siebert P.D."/>
        <person name="Huang B.C."/>
      </authorList>
      <dbReference type="PubMed" id="9122171"/>
      <dbReference type="DOI" id="10.1073/pnas.94.6.2198"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND DELTALF)</scope>
    <scope>ALTERNATIVE SPLICING</scope>
    <scope>TISSUE SPECIFICITY</scope>
    <source>
      <tissue>Lung</tissue>
    </source>
  </reference>
  <reference key="4">
    <citation type="journal article" date="2001" name="Sheng Wu Gong Cheng Xue Bao" volume="17" first="385" last="387">
      <title>cDNA cloning and sequence analysis of human lactoferrin.</title>
      <authorList>
        <person name="Cheng H."/>
        <person name="Chen X.Z."/>
        <person name="Huan L.D."/>
      </authorList>
      <dbReference type="PubMed" id="11702692"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
    <scope>VARIANTS ARG-22 INS; THR-29; ARG-47 AND ASP-579</scope>
    <source>
      <tissue>Mammary gland</tissue>
    </source>
  </reference>
  <reference key="5">
    <citation type="journal article" date="2003" name="Indian J. Biochem. Biophys." volume="40" first="14" last="21">
      <title>Crystal structure of human seminal diferric lactoferrin at 3.4 Angstrom resolution.</title>
      <authorList>
        <person name="Kumar J."/>
        <person name="Weber W."/>
        <person name="Munchau S."/>
        <person name="Yadav S."/>
        <person name="Singh S.B."/>
        <person name="Saravanan K."/>
        <person name="Paramasivam M."/>
        <person name="Sharma S."/>
        <person name="Kaur P."/>
        <person name="Bhushan A."/>
        <person name="Srinivasan A."/>
        <person name="Betzel C."/>
        <person name="Singh T.P."/>
      </authorList>
      <dbReference type="PubMed" id="22900286"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
    <scope>X-RAY CRYSTALLOGRAPHY (3.40 ANGSTROMS) OF 22-710 IN COMPLEX WITH IRON AND CARBONATE</scope>
    <scope>FUNCTION</scope>
    <scope>VARIANTS ARG-22 INS; THR-29; ARG-47 AND ASP-579</scope>
    <source>
      <tissue>Seminal vesicle</tissue>
    </source>
  </reference>
  <reference key="6">
    <citation type="journal article" date="2003" name="Infect. Immun." volume="71" first="6141" last="6147">
      <title>One of two human lactoferrin variants exhibits increased antibacterial and transcriptional activation activities and is associated with localized juvenile periodontitis.</title>
      <authorList>
        <person name="Velliyagounder K."/>
        <person name="Kaplan J.B."/>
        <person name="Furgang D."/>
        <person name="Legarda D."/>
        <person name="Diamond G."/>
        <person name="Parkin R.E."/>
        <person name="Fine D.H."/>
      </authorList>
      <dbReference type="PubMed" id="14573629"/>
      <dbReference type="DOI" id="10.1128/iai.71.11.6141-6147.2003"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
    <scope>PROTEIN SEQUENCE OF 20-30</scope>
    <scope>FUNCTION</scope>
    <scope>VARIANTS ARG-22 INS; THR-29 AND ARG-47</scope>
    <source>
      <tissue>Blood</tissue>
    </source>
  </reference>
  <reference key="7">
    <citation type="submission" date="1992-02" db="EMBL/GenBank/DDBJ databases">
      <title>Human neutrophil lactoferrin coding and 5' flanking region DNA sequences.</title>
      <authorList>
        <person name="Wei X."/>
        <person name="Han J."/>
        <person name="Rado T.A."/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
    <source>
      <tissue>Bone marrow</tissue>
    </source>
  </reference>
  <reference key="8">
    <citation type="submission" date="1992-05" db="EMBL/GenBank/DDBJ databases">
      <authorList>
        <person name="Conneely O.M."/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
    <scope>VARIANTS ARG-22 INS; THR-29 AND ARG-47</scope>
    <source>
      <tissue>Prostate</tissue>
    </source>
  </reference>
  <reference key="9">
    <citation type="submission" date="2002-10" db="EMBL/GenBank/DDBJ databases">
      <authorList>
        <person name="Shi Y.-Q."/>
        <person name="Zhang Y."/>
        <person name="Zheng Y.-M."/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
    <scope>VARIANTS ARG-22 INS; THR-29; ARG-47 AND ASP-579</scope>
    <source>
      <tissue>Mammary gland</tissue>
    </source>
  </reference>
  <reference key="10">
    <citation type="submission" date="2003-12" db="EMBL/GenBank/DDBJ databases">
      <title>Identification of a growth inhibition gene.</title>
      <authorList>
        <person name="Kim J.W."/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
    <scope>VARIANTS ARG-22 INS AND CYS-422</scope>
  </reference>
  <reference key="11">
    <citation type="submission" date="2008-04" db="EMBL/GenBank/DDBJ databases">
      <title>Mutations in ELA2 and LTF genes.</title>
      <authorList>
        <person name="Allayous C."/>
        <person name="Marianne-Pepin T."/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
    <scope>VARIANTS ARG-22 INS; THR-29 AND ARG-47</scope>
  </reference>
  <reference key="12">
    <citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
      <title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
      <authorList>
        <person name="Ota T."/>
        <person name="Suzuki Y."/>
        <person name="Nishikawa T."/>
        <person name="Otsuki T."/>
        <person name="Sugiyama T."/>
        <person name="Irie R."/>
        <person name="Wakamatsu A."/>
        <person name="Hayashi K."/>
        <person name="Sato H."/>
        <person name="Nagai K."/>
        <person name="Kimura K."/>
        <person name="Makita H."/>
        <person name="Sekine M."/>
        <person name="Obayashi M."/>
        <person name="Nishi T."/>
        <person name="Shibahara T."/>
        <person name="Tanaka T."/>
        <person name="Ishii S."/>
        <person name="Yamamoto J."/>
        <person name="Saito K."/>
        <person name="Kawai Y."/>
        <person name="Isono Y."/>
        <person name="Nakamura Y."/>
        <person name="Nagahari K."/>
        <person name="Murakami K."/>
        <person name="Yasuda T."/>
        <person name="Iwayanagi T."/>
        <person name="Wagatsuma M."/>
        <person name="Shiratori A."/>
        <person name="Sudo H."/>
        <person name="Hosoiri T."/>
        <person name="Kaku Y."/>
        <person name="Kodaira H."/>
        <person name="Kondo H."/>
        <person name="Sugawara M."/>
        <person name="Takahashi M."/>
        <person name="Kanda K."/>
        <person name="Yokoi T."/>
        <person name="Furuya T."/>
        <person name="Kikkawa E."/>
        <person name="Omura Y."/>
        <person name="Abe K."/>
        <person name="Kamihara K."/>
        <person name="Katsuta N."/>
        <person name="Sato K."/>
        <person name="Tanikawa M."/>
        <person name="Yamazaki M."/>
        <person name="Ninomiya K."/>
        <person name="Ishibashi T."/>
        <person name="Yamashita H."/>
        <person name="Murakawa K."/>
        <person name="Fujimori K."/>
        <person name="Tanai H."/>
        <person name="Kimata M."/>
        <person name="Watanabe M."/>
        <person name="Hiraoka S."/>
        <person name="Chiba Y."/>
        <person name="Ishida S."/>
        <person name="Ono Y."/>
        <person name="Takiguchi S."/>
        <person name="Watanabe S."/>
        <person name="Yosida M."/>
        <person name="Hotuta T."/>
        <person name="Kusano J."/>
        <person name="Kanehori K."/>
        <person name="Takahashi-Fujii A."/>
        <person name="Hara H."/>
        <person name="Tanase T.-O."/>
        <person name="Nomura Y."/>
        <person name="Togiya S."/>
        <person name="Komai F."/>
        <person name="Hara R."/>
        <person name="Takeuchi K."/>
        <person name="Arita M."/>
        <person name="Imose N."/>
        <person name="Musashino K."/>
        <person name="Yuuki H."/>
        <person name="Oshima A."/>
        <person name="Sasaki N."/>
        <person name="Aotsuka S."/>
        <person name="Yoshikawa Y."/>
        <person name="Matsunawa H."/>
        <person name="Ichihara T."/>
        <person name="Shiohata N."/>
        <person name="Sano S."/>
        <person name="Moriya S."/>
        <person name="Momiyama H."/>
        <person name="Satoh N."/>
        <person name="Takami S."/>
        <person name="Terashima Y."/>
        <person name="Suzuki O."/>
        <person name="Nakagawa S."/>
        <person name="Senoh A."/>
        <person name="Mizoguchi H."/>
        <person name="Goto Y."/>
        <person name="Shimizu F."/>
        <person name="Wakebe H."/>
        <person name="Hishigaki H."/>
        <person name="Watanabe T."/>
        <person name="Sugiyama A."/>
        <person name="Takemoto M."/>
        <person name="Kawakami B."/>
        <person name="Yamazaki M."/>
        <person name="Watanabe K."/>
        <person name="Kumagai A."/>
        <person name="Itakura S."/>
        <person name="Fukuzumi Y."/>
        <person name="Fujimori Y."/>
        <person name="Komiyama M."/>
        <person name="Tashiro H."/>
        <person name="Tanigami A."/>
        <person name="Fujiwara T."/>
        <person name="Ono T."/>
        <person name="Yamada K."/>
        <person name="Fujii Y."/>
        <person name="Ozaki K."/>
        <person name="Hirao M."/>
        <person name="Ohmori Y."/>
        <person name="Kawabata A."/>
        <person name="Hikiji T."/>
        <person name="Kobatake N."/>
        <person name="Inagaki H."/>
        <person name="Ikema Y."/>
        <person name="Okamoto S."/>
        <person name="Okitani R."/>
        <person name="Kawakami T."/>
        <person name="Noguchi S."/>
        <person name="Itoh T."/>
        <person name="Shigeta K."/>
        <person name="Senba T."/>
        <person name="Matsumura K."/>
        <person name="Nakajima Y."/>
        <person name="Mizuno T."/>
        <person name="Morinaga M."/>
        <person name="Sasaki M."/>
        <person name="Togashi T."/>
        <person name="Oyama M."/>
        <person name="Hata H."/>
        <person name="Watanabe M."/>
        <person name="Komatsu T."/>
        <person name="Mizushima-Sugano J."/>
        <person name="Satoh T."/>
        <person name="Shirai Y."/>
        <person name="Takahashi Y."/>
        <person name="Nakagawa K."/>
        <person name="Okumura K."/>
        <person name="Nagase T."/>
        <person name="Nomura N."/>
        <person name="Kikuchi H."/>
        <person name="Masuho Y."/>
        <person name="Yamashita R."/>
        <person name="Nakai K."/>
        <person name="Yada T."/>
        <person name="Nakamura Y."/>
        <person name="Ohara O."/>
        <person name="Isogai T."/>
        <person name="Sugano S."/>
      </authorList>
      <dbReference type="PubMed" id="14702039"/>
      <dbReference type="DOI" id="10.1038/ng1285"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND DELTALF)</scope>
    <scope>VARIANT ARG-22 INS</scope>
    <source>
      <tissue>Lung</tissue>
      <tissue>Trachea</tissue>
    </source>
  </reference>
  <reference key="13">
    <citation type="journal article" date="2006" name="Nature" volume="440" first="1194" last="1198">
      <title>The DNA sequence, annotation and analysis of human chromosome 3.</title>
      <authorList>
        <person name="Muzny D.M."/>
        <person name="Scherer S.E."/>
        <person name="Kaul R."/>
        <person name="Wang J."/>
        <person name="Yu J."/>
        <person name="Sudbrak R."/>
        <person name="Buhay C.J."/>
        <person name="Chen R."/>
        <person name="Cree A."/>
        <person name="Ding Y."/>
        <person name="Dugan-Rocha S."/>
        <person name="Gill R."/>
        <person name="Gunaratne P."/>
        <person name="Harris R.A."/>
        <person name="Hawes A.C."/>
        <person name="Hernandez J."/>
        <person name="Hodgson A.V."/>
        <person name="Hume J."/>
        <person name="Jackson A."/>
        <person name="Khan Z.M."/>
        <person name="Kovar-Smith C."/>
        <person name="Lewis L.R."/>
        <person name="Lozado R.J."/>
        <person name="Metzker M.L."/>
        <person name="Milosavljevic A."/>
        <person name="Miner G.R."/>
        <person name="Morgan M.B."/>
        <person name="Nazareth L.V."/>
        <person name="Scott G."/>
        <person name="Sodergren E."/>
        <person name="Song X.-Z."/>
        <person name="Steffen D."/>
        <person name="Wei S."/>
        <person name="Wheeler D.A."/>
        <person name="Wright M.W."/>
        <person name="Worley K.C."/>
        <person name="Yuan Y."/>
        <person name="Zhang Z."/>
        <person name="Adams C.Q."/>
        <person name="Ansari-Lari M.A."/>
        <person name="Ayele M."/>
        <person name="Brown M.J."/>
        <person name="Chen G."/>
        <person name="Chen Z."/>
        <person name="Clendenning J."/>
        <person name="Clerc-Blankenburg K.P."/>
        <person name="Chen R."/>
        <person name="Chen Z."/>
        <person name="Davis C."/>
        <person name="Delgado O."/>
        <person name="Dinh H.H."/>
        <person name="Dong W."/>
        <person name="Draper H."/>
        <person name="Ernst S."/>
        <person name="Fu G."/>
        <person name="Gonzalez-Garay M.L."/>
        <person name="Garcia D.K."/>
        <person name="Gillett W."/>
        <person name="Gu J."/>
        <person name="Hao B."/>
        <person name="Haugen E."/>
        <person name="Havlak P."/>
        <person name="He X."/>
        <person name="Hennig S."/>
        <person name="Hu S."/>
        <person name="Huang W."/>
        <person name="Jackson L.R."/>
        <person name="Jacob L.S."/>
        <person name="Kelly S.H."/>
        <person name="Kube M."/>
        <person name="Levy R."/>
        <person name="Li Z."/>
        <person name="Liu B."/>
        <person name="Liu J."/>
        <person name="Liu W."/>
        <person name="Lu J."/>
        <person name="Maheshwari M."/>
        <person name="Nguyen B.-V."/>
        <person name="Okwuonu G.O."/>
        <person name="Palmeiri A."/>
        <person name="Pasternak S."/>
        <person name="Perez L.M."/>
        <person name="Phelps K.A."/>
        <person name="Plopper F.J."/>
        <person name="Qiang B."/>
        <person name="Raymond C."/>
        <person name="Rodriguez R."/>
        <person name="Saenphimmachak C."/>
        <person name="Santibanez J."/>
        <person name="Shen H."/>
        <person name="Shen Y."/>
        <person name="Subramanian S."/>
        <person name="Tabor P.E."/>
        <person name="Verduzco D."/>
        <person name="Waldron L."/>
        <person name="Wang J."/>
        <person name="Wang J."/>
        <person name="Wang Q."/>
        <person name="Williams G.A."/>
        <person name="Wong G.K.-S."/>
        <person name="Yao Z."/>
        <person name="Zhang J."/>
        <person name="Zhang X."/>
        <person name="Zhao G."/>
        <person name="Zhou J."/>
        <person name="Zhou Y."/>
        <person name="Nelson D."/>
        <person name="Lehrach H."/>
        <person name="Reinhardt R."/>
        <person name="Naylor S.L."/>
        <person name="Yang H."/>
        <person name="Olson M."/>
        <person name="Weinstock G."/>
        <person name="Gibbs R.A."/>
      </authorList>
      <dbReference type="PubMed" id="16641997"/>
      <dbReference type="DOI" id="10.1038/nature04728"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
  </reference>
  <reference key="14">
    <citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
      <title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
      <authorList>
        <consortium name="The MGC Project Team"/>
      </authorList>
      <dbReference type="PubMed" id="15489334"/>
      <dbReference type="DOI" id="10.1101/gr.2596504"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
    <scope>VARIANT ARG-22 INS</scope>
    <source>
      <tissue>Prostate</tissue>
    </source>
  </reference>
  <reference key="15">
    <citation type="journal article" date="1992" name="Mol. Endocrinol." volume="6" first="1969" last="1981">
      <title>Differential molecular mechanism of the estrogen action that regulates lactoferrin gene in human and mouse.</title>
      <authorList>
        <person name="Teng C.T."/>
        <person name="Liu Y."/>
        <person name="Yang N."/>
        <person name="Walmer D."/>
        <person name="Panella T."/>
      </authorList>
      <dbReference type="PubMed" id="1480183"/>
      <dbReference type="DOI" id="10.1210/mend.6.11.1480183"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-15</scope>
  </reference>
  <reference key="16">
    <citation type="journal article" date="1990" name="Nucleic Acids Res." volume="18" first="4013" last="4013">
      <title>Nucleotide sequence of human lactoferrin cDNA.</title>
      <authorList>
        <person name="Powell M.J."/>
        <person name="Ogden J.E."/>
      </authorList>
      <dbReference type="PubMed" id="2374734"/>
      <dbReference type="DOI" id="10.1093/nar/18.13.4013"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA] OF 3-710 (ISOFORM 1)</scope>
    <scope>VARIANT ARG-22 INS</scope>
    <source>
      <tissue>Mammary gland</tissue>
    </source>
  </reference>
  <reference key="17">
    <citation type="submission" date="1991-12" db="EMBL/GenBank/DDBJ databases">
      <title>Molecular cloning and sequence analysis of human lactoferrin.</title>
      <authorList>
        <person name="Liang Q."/>
        <person name="Jimenez-Flores R."/>
        <person name="Richardson T."/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA] OF 6-710 (ISOFORM 1)</scope>
    <scope>VARIANT ARG-22 INS</scope>
    <source>
      <tissue>Mammary gland</tissue>
    </source>
  </reference>
  <reference key="18">
    <citation type="journal article" date="1984" name="Eur. J. Biochem." volume="145" first="659" last="676">
      <title>Human lactotransferrin: amino acid sequence and structural comparisons with other transferrins.</title>
      <authorList>
        <person name="Metz-Boutigue M.-H."/>
        <person name="Jolles J."/>
        <person name="Mazurier J."/>
        <person name="Schoentgen F."/>
        <person name="Legrand D."/>
        <person name="Spik G."/>
        <person name="Montreuil J."/>
        <person name="Jolles P."/>
      </authorList>
      <dbReference type="PubMed" id="6510420"/>
      <dbReference type="DOI" id="10.1111/j.1432-1033.1984.tb08607.x"/>
    </citation>
    <scope>PROTEIN SEQUENCE OF 20-710 (ISOFORM 1)</scope>
    <scope>DISULFIDE BONDS</scope>
  </reference>
  <reference key="19">
    <citation type="journal article" date="1981" name="Biochim. Biophys. Acta" volume="670" first="243" last="254">
      <title>The present state of the human lactotransferrin sequence. Study and alignment of the cyanogen bromide fragments and characterization of N- and C-terminal domains.</title>
      <authorList>
        <person name="Metz-Boutigue M.-H."/>
        <person name="Mazurier J."/>
        <person name="Jolles J."/>
        <person name="Spik G."/>
        <person name="Montreuil J."/>
        <person name="Jolles P."/>
      </authorList>
      <dbReference type="PubMed" id="6794640"/>
      <dbReference type="DOI" id="10.1016/0005-2795(81)90016-7"/>
    </citation>
    <scope>PRELIMINARY PROTEIN SEQUENCE OF 20-72; 133-170; 256-277; 359-528 AND 608-663 (ISOFORM 1)</scope>
  </reference>
  <reference key="20">
    <citation type="journal article" date="1992" name="Biochim. Biophys. Acta" volume="1121" first="130" last="136">
      <title>Identification of the bactericidal domain of lactoferrin.</title>
      <authorList>
        <person name="Bellamy W."/>
        <person name="Takase M."/>
        <person name="Yamauchi K."/>
        <person name="Wakabayashi H."/>
        <person name="Kawase K."/>
        <person name="Tomita M."/>
      </authorList>
      <dbReference type="PubMed" id="1599934"/>
      <dbReference type="DOI" id="10.1016/0167-4838(92)90346-f"/>
    </citation>
    <scope>PROTEIN SEQUENCE OF 20-65 (ISOFORM 1)</scope>
    <scope>IDENTIFICATION OF LACTOFERRICIN PEPTIDE</scope>
    <scope>FUNCTION</scope>
    <scope>SYNTHESIS OF 36-58</scope>
    <source>
      <tissue>Milk</tissue>
    </source>
  </reference>
  <reference key="21">
    <citation type="journal article" date="1994" name="J. Biol. Chem." volume="269" first="23661" last="23667">
      <title>Delineation of the glycosaminoglycan-binding site in the human inflammatory response protein lactoferrin.</title>
      <authorList>
        <person name="Mann D.M."/>
        <person name="Romm E."/>
        <person name="Migliorini M."/>
      </authorList>
      <dbReference type="PubMed" id="8089135"/>
      <dbReference type="DOI" id="10.1016/s0021-9258(17)31566-1"/>
    </citation>
    <scope>PROTEIN SEQUENCE OF 20-40 (ISOFORM 1)</scope>
    <scope>FUNCTION</scope>
    <scope>GLYCOSAMINOGLYCAN BINDING</scope>
    <scope>SYNTHESIS OF 20-51; 20-45 AND 25-51</scope>
    <source>
      <tissue>Milk</tissue>
    </source>
  </reference>
  <reference key="22">
    <citation type="journal article" date="1995" name="Nihon Hoigaku Zasshi" volume="49" first="281" last="293">
      <title>Characterization of the 84-kDa protein with ABH activity in human seminal plasma.</title>
      <authorList>
        <person name="Sato I."/>
      </authorList>
      <dbReference type="PubMed" id="8551695"/>
    </citation>
    <scope>PROTEIN SEQUENCE OF 20-56 (ISOFORM 1)</scope>
    <source>
      <tissue>Seminal plasma</tissue>
    </source>
  </reference>
  <reference key="23">
    <citation type="journal article" date="2005" name="Antimicrob. Agents Chemother." volume="49" first="3387" last="3395">
      <title>Human lactoferricin is partially folded in aqueous solution and is better stabilized in a membrane mimetic solvent.</title>
      <authorList>
        <person name="Hunter H.N."/>
        <person name="Demcoe A.R."/>
        <person name="Jenssen H."/>
        <person name="Gutteberg T.J."/>
        <person name="Vogel H.J."/>
      </authorList>
      <dbReference type="PubMed" id="16048952"/>
      <dbReference type="DOI" id="10.1128/aac.49.8.3387-3395.2005"/>
    </citation>
    <scope>PROTEIN SEQUENCE OF 24-32; 38-43; 50-57 AND 59-67 (ISOFORM 1)</scope>
    <scope>STRUCTURE BY NMR OF 20-67 (LACTOFERRICIN)</scope>
    <scope>MASS SPECTROMETRY</scope>
    <scope>DISULFIDE BONDS</scope>
    <source>
      <tissue>Milk</tissue>
    </source>
  </reference>
  <reference key="24">
    <citation type="journal article" date="2015" name="J. Proteome Res." volume="14" first="2649" last="2658">
      <title>Human basal tear peptidome characterization by CID, HCD, and ETD followed by in silico and in vitro analyses for antimicrobial peptide identification.</title>
      <authorList>
        <person name="Azkargorta M."/>
        <person name="Soria J."/>
        <person name="Ojeda C."/>
        <person name="Guzman F."/>
        <person name="Acera A."/>
        <person name="Iloro I."/>
        <person name="Suarez T."/>
        <person name="Elortza F."/>
      </authorList>
      <dbReference type="PubMed" id="25946035"/>
      <dbReference type="DOI" id="10.1021/acs.jproteome.5b00179"/>
    </citation>
    <scope>PROTEIN SEQUENCE OF 38-57; 235-261; 509-525 AND 651-710</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
    <source>
      <tissue>Tear</tissue>
    </source>
  </reference>
  <reference key="25">
    <citation type="submission" date="1997-03" db="EMBL/GenBank/DDBJ databases">
      <authorList>
        <person name="McCombie W.R."/>
        <person name="Wilson R."/>
        <person name="Chen E."/>
        <person name="Gibbs R."/>
        <person name="Zuo L."/>
        <person name="Johnson D."/>
        <person name="Nhan M."/>
        <person name="Parnell L."/>
        <person name="Dedhia N."/>
        <person name="Ansari A."/>
        <person name="Mardis E."/>
        <person name="Schutz K."/>
        <person name="Gnoj L."/>
        <person name="la Bastide M."/>
        <person name="Kaplan N."/>
        <person name="Greco T."/>
        <person name="Touchman J."/>
        <person name="Muzny D."/>
        <person name="Chen C.N."/>
        <person name="Evans C."/>
        <person name="Fitzgerald M."/>
        <person name="See L.H."/>
        <person name="Tang M."/>
        <person name="Porcel B.M."/>
        <person name="Dragan Y."/>
        <person name="Giacalone J."/>
        <person name="Pae A."/>
        <person name="Powell E."/>
        <person name="Solinsky K.A."/>
        <person name="Desilva U."/>
        <person name="Diaz-Perez S."/>
        <person name="Zhou X."/>
        <person name="Yu Y."/>
        <person name="Watanabe M."/>
        <person name="Doggett N."/>
        <person name="Garcia D."/>
        <person name="Sagripanti J.L."/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 236-710</scope>
    <scope>VARIANT ASP-579</scope>
  </reference>
  <reference key="26">
    <citation type="journal article" date="1987" name="Blood" volume="70" first="989" last="993">
      <title>Isolation of lactoferrin cDNA from a human myeloid library and expression of mRNA during normal and leukemic myelopoiesis.</title>
      <authorList>
        <person name="Rado T.A."/>
        <person name="Wei X."/>
        <person name="Benz E.J. Jr."/>
      </authorList>
      <dbReference type="PubMed" id="3477300"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA] OF 435-710</scope>
    <source>
      <tissue>Myeloid</tissue>
    </source>
  </reference>
  <reference key="27">
    <citation type="journal article" date="1982" name="FEBS Lett." volume="142" first="107" last="110">
      <title>An 88 amino acid long C-terminal sequence of human lactotransferrin.</title>
      <authorList>
        <person name="Metz-Boutigue M.-H."/>
        <person name="Jolles J."/>
        <person name="Mazurier J."/>
        <person name="Spik G."/>
        <person name="Montreuil J."/>
        <person name="Jolles P."/>
      </authorList>
      <dbReference type="PubMed" id="7049727"/>
      <dbReference type="DOI" id="10.1016/0014-5793(82)80229-9"/>
    </citation>
    <scope>PROTEIN SEQUENCE OF 608-710</scope>
  </reference>
  <reference key="28">
    <citation type="journal article" date="1982" name="Infect. Immun." volume="35" first="792" last="799">
      <title>Bactericidal activity of human lactoferrin: differentiation from the stasis of iron deprivation.</title>
      <authorList>
        <person name="Arnold R.R."/>
        <person name="Russell J.E."/>
        <person name="Champion W.J."/>
        <person name="Brewer M."/>
        <person name="Gauthier J.J."/>
      </authorList>
      <dbReference type="PubMed" id="6802759"/>
      <dbReference type="DOI" id="10.1128/iai.35.3.792-799.1982"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="29">
    <citation type="journal article" date="1985" name="Blood" volume="65" first="423" last="432">
      <title>Ultrastructural localization of lactoferrin and myeloperoxidase in human neutrophils by immunogold.</title>
      <authorList>
        <person name="Cramer E."/>
        <person name="Pryzwansky K.B."/>
        <person name="Villeval J.L."/>
        <person name="Testa U."/>
        <person name="Breton-Gorius J."/>
      </authorList>
      <dbReference type="PubMed" id="2981589"/>
    </citation>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>TISSUE SPECIFICITY</scope>
  </reference>
  <reference key="30">
    <citation type="journal article" date="1988" name="Infect. Immun." volume="56" first="2774" last="2781">
      <title>Damage of the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin.</title>
      <authorList>
        <person name="Ellison R.T. III"/>
        <person name="Giehl T.J."/>
        <person name="LaForce F.M."/>
      </authorList>
      <dbReference type="PubMed" id="3169987"/>
      <dbReference type="DOI" id="10.1128/iai.56.11.2774-2781.1988"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="31">
    <citation type="journal article" date="1990" name="Agric. Biol. Chem." volume="54" first="1803" last="1810">
      <title>Isolation and characterization of opioid antagonist peptides derived from human lactoferrin.</title>
      <authorList>
        <person name="Tani F."/>
        <person name="Iio K."/>
        <person name="Chiba H."/>
        <person name="Yoshikawa M."/>
      </authorList>
      <dbReference type="PubMed" id="1369293"/>
      <dbReference type="DOI" id="10.1271/bbb1961.54.1803"/>
    </citation>
    <scope>CHARACTERIZATION OF LACTOFERROXINS</scope>
  </reference>
  <reference key="32">
    <citation type="journal article" date="1997" name="Biochem. J." volume="328" first="145" last="151">
      <title>N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA.</title>
      <authorList>
        <person name="van Berkel P.H."/>
        <person name="Geerts M.E."/>
        <person name="van Veen H.A."/>
        <person name="Mericskay M."/>
        <person name="de Boer H.A."/>
        <person name="Nuijens J.H."/>
      </authorList>
      <dbReference type="PubMed" id="9359845"/>
      <dbReference type="DOI" id="10.1042/bj3280145"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>MUTAGENESIS OF 20-G--R-23</scope>
  </reference>
  <reference key="33">
    <citation type="journal article" date="2000" name="Antimicrob. Agents Chemother." volume="44" first="3257" last="3263">
      <title>Candidacidal activities of human lactoferrin peptides derived from the N terminus.</title>
      <authorList>
        <person name="Lupetti A."/>
        <person name="Paulusma-Annema A."/>
        <person name="Welling M.M."/>
        <person name="Senesi S."/>
        <person name="van Dissel J.T."/>
        <person name="Nibbering P.H."/>
      </authorList>
      <dbReference type="PubMed" id="11083624"/>
      <dbReference type="DOI" id="10.1128/aac.44.12.3257-3263.2000"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="34">
    <citation type="journal article" date="2000" name="Kidney Int." volume="57" first="2004" last="2010">
      <title>Expression of lactoferrin in the kidney: implications for innate immunity and iron metabolism.</title>
      <authorList>
        <person name="Abrink M."/>
        <person name="Larsson E."/>
        <person name="Gobl A."/>
        <person name="Hellman L."/>
      </authorList>
      <dbReference type="PubMed" id="10792619"/>
      <dbReference type="DOI" id="10.1046/j.1523-1755.2000.00050.x"/>
    </citation>
    <scope>TISSUE SPECIFICITY</scope>
  </reference>
  <reference key="35">
    <citation type="journal article" date="2001" name="Infect. Immun." volume="69" first="1469" last="1476">
      <title>Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria.</title>
      <authorList>
        <person name="Nibbering P.H."/>
        <person name="Ravensbergen E."/>
        <person name="Welling M.M."/>
        <person name="van Berkel L.A."/>
        <person name="van Berkel P.H."/>
        <person name="Pauwels E.K."/>
        <person name="Nuijens J.H."/>
      </authorList>
      <dbReference type="PubMed" id="11179314"/>
      <dbReference type="DOI" id="10.1128/iai.69.3.1469-1476.2001"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>SYNTHESIS OF 20-29 AND 39-49</scope>
    <scope>MUTAGENESIS OF 20-GLY--ARG-22</scope>
  </reference>
  <reference key="36">
    <citation type="journal article" date="2002" name="Nature" volume="417" first="552" last="555">
      <title>A component of innate immunity prevents bacterial biofilm development.</title>
      <authorList>
        <person name="Singh P.K."/>
        <person name="Parsek M.R."/>
        <person name="Greenberg E.P."/>
        <person name="Welsh M.J."/>
      </authorList>
      <dbReference type="PubMed" id="12037568"/>
      <dbReference type="DOI" id="10.1038/417552a"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="37">
    <citation type="journal article" date="2003" name="Biochem. Biophys. Res. Commun." volume="301" first="472" last="479">
      <title>An intronic alternative promoter of the human lactoferrin gene is activated by Ets.</title>
      <authorList>
        <person name="Liu D."/>
        <person name="Wang X."/>
        <person name="Zhang Z."/>
        <person name="Teng C.T."/>
      </authorList>
      <dbReference type="PubMed" id="12565886"/>
      <dbReference type="DOI" id="10.1016/s0006-291x(02)03077-2"/>
    </citation>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>ALTERNATIVE PROMOTER USAGE</scope>
  </reference>
  <reference key="38">
    <citation type="journal article" date="2003" name="Biochemistry (Mosc.)" volume="68" first="217" last="227">
      <title>Potassium efflux induced by a new lactoferrin-derived peptide mimicking the effect of native human lactoferrin on the bacterial cytoplasmic membrane.</title>
      <authorList>
        <person name="Viejo-Diaz M."/>
        <person name="Andres M.T."/>
        <person name="Perez-Gil J."/>
        <person name="Sanchez M."/>
        <person name="Fierro J.F."/>
      </authorList>
      <dbReference type="PubMed" id="12693969"/>
      <dbReference type="DOI" id="10.1023/a:1022657630698"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>SYNTHESIS OF 36-58 AND 171-201 (KALIOCIN-1)</scope>
  </reference>
  <reference key="39">
    <citation type="journal article" date="2003" name="Mol. Microbiol." volume="47" first="607" last="617">
      <title>Human milk lactoferrin is a serine protease that cleaves Haemophilus surface proteins at arginine-rich sites.</title>
      <authorList>
        <person name="Hendrixson D.R."/>
        <person name="Qiu J."/>
        <person name="Shewry S.C."/>
        <person name="Fink D.L."/>
        <person name="Petty S."/>
        <person name="Baker E.N."/>
        <person name="Plaut A.G."/>
        <person name="St Geme J.W. III"/>
      </authorList>
      <dbReference type="PubMed" id="12535064"/>
      <dbReference type="DOI" id="10.1046/j.1365-2958.2003.03327.x"/>
    </citation>
    <scope>FUNCTION AS A PROTEASE</scope>
    <scope>CATALYTIC ACTIVITY</scope>
    <scope>ACTIVE SITE</scope>
    <scope>MUTAGENESIS OF LYS-92; PRO-270 AND SER-278</scope>
  </reference>
  <reference key="40">
    <citation type="journal article" date="2004" name="BioMetals" volume="17" first="325" last="329">
      <title>Expression of delta-lactoferrin induces cell cycle arrest.</title>
      <authorList>
        <person name="Breton M."/>
        <person name="Mariller C."/>
        <person name="Benaissa M."/>
        <person name="Caillaux K."/>
        <person name="Browaeys E."/>
        <person name="Masson M."/>
        <person name="Vilain J.P."/>
        <person name="Mazurier J."/>
        <person name="Pierce A."/>
      </authorList>
      <dbReference type="PubMed" id="15222485"/>
      <dbReference type="DOI" id="10.1023/b:biom.0000027712.81056.13"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>SUBCELLULAR LOCATION (DELTALF)</scope>
  </reference>
  <reference key="41">
    <citation type="journal article" date="2004" name="Endocrinology" volume="145" first="4366" last="4374">
      <title>Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo.</title>
      <authorList>
        <person name="Cornish J."/>
        <person name="Callon K.E."/>
        <person name="Naot D."/>
        <person name="Palmano K.P."/>
        <person name="Banovic T."/>
        <person name="Bava U."/>
        <person name="Watson M."/>
        <person name="Lin J.M."/>
        <person name="Tong P.C."/>
        <person name="Chen Q."/>
        <person name="Chan V.A."/>
        <person name="Reid H.E."/>
        <person name="Fazzalari N."/>
        <person name="Baker H.M."/>
        <person name="Baker E.N."/>
        <person name="Haggarty N.W."/>
        <person name="Grey A.B."/>
        <person name="Reid I.R."/>
      </authorList>
      <dbReference type="PubMed" id="15166119"/>
      <dbReference type="DOI" id="10.1210/en.2003-1307"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="42">
    <citation type="journal article" date="2006" name="FEBS Lett." volume="580" first="4332" last="4336">
      <title>Human lactoferrin upregulates expression of KDR/Flk-1 and stimulates VEGF-A-mediated endothelial cell proliferation and migration.</title>
      <authorList>
        <person name="Kim C.W."/>
        <person name="Son K.N."/>
        <person name="Choi S.Y."/>
        <person name="Kim J."/>
      </authorList>
      <dbReference type="PubMed" id="16842782"/>
      <dbReference type="DOI" id="10.1016/j.febslet.2006.06.091"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="43">
    <citation type="journal article" date="2007" name="Antiviral Res." volume="75" first="258" last="265">
      <title>The anti-papillomavirus activity of human and bovine lactoferricin.</title>
      <authorList>
        <person name="Mistry N."/>
        <person name="Drobni P."/>
        <person name="Naslund J."/>
        <person name="Sunkari V.G."/>
        <person name="Jenssen H."/>
        <person name="Evander M."/>
      </authorList>
      <dbReference type="PubMed" id="17481742"/>
      <dbReference type="DOI" id="10.1016/j.antiviral.2007.03.012"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="44">
    <citation type="journal article" date="2007" name="Biol. Reprod." volume="77" first="476" last="484">
      <title>Characterization of an eppin protein complex from human semen and spermatozoa.</title>
      <authorList>
        <person name="Wang Z."/>
        <person name="Widgren E.E."/>
        <person name="Richardson R.T."/>
        <person name="O'Rand M.G."/>
      </authorList>
      <dbReference type="PubMed" id="17567961"/>
      <dbReference type="DOI" id="10.1095/biolreprod.107.060194"/>
    </citation>
    <scope>IDENTIFICATION IN A COMPLEX WITH CLU; SEMG1 AND EPPIN</scope>
  </reference>
  <reference key="45">
    <citation type="journal article" date="2007" name="J. Virol." volume="81" first="954" last="963">
      <title>Adenoviruses use lactoferrin as a bridge for CAR-independent binding to and infection of epithelial cells.</title>
      <authorList>
        <person name="Johansson C."/>
        <person name="Jonsson M."/>
        <person name="Marttila M."/>
        <person name="Persson D."/>
        <person name="Fan X.L."/>
        <person name="Skog J."/>
        <person name="Frangsmyr L."/>
        <person name="Wadell G."/>
        <person name="Arnberg N."/>
      </authorList>
      <dbReference type="PubMed" id="17079302"/>
      <dbReference type="DOI" id="10.1128/jvi.01995-06"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="46">
    <citation type="journal article" date="2008" name="Proteomics" volume="8" first="3833" last="3847">
      <title>Identification of N-linked glycoproteins in human milk by hydrophilic interaction liquid chromatography and mass spectrometry.</title>
      <authorList>
        <person name="Picariello G."/>
        <person name="Ferranti P."/>
        <person name="Mamone G."/>
        <person name="Roepstorff P."/>
        <person name="Addeo F."/>
      </authorList>
      <dbReference type="PubMed" id="18780401"/>
      <dbReference type="DOI" id="10.1002/pmic.200701057"/>
    </citation>
    <scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-156; ASN-497 AND ASN-642</scope>
    <source>
      <tissue>Milk</tissue>
    </source>
  </reference>
  <reference key="47">
    <citation type="journal article" date="2009" name="J. Clin. Invest." volume="119" first="20" last="32">
      <title>Apoptotic human cells inhibit migration of granulocytes via release of lactoferrin.</title>
      <authorList>
        <person name="Bournazou I."/>
        <person name="Pound J.D."/>
        <person name="Duffin R."/>
        <person name="Bournazos S."/>
        <person name="Melville L.A."/>
        <person name="Brown S.B."/>
        <person name="Rossi A.G."/>
        <person name="Gregory C.D."/>
      </authorList>
      <dbReference type="PubMed" id="19033648"/>
      <dbReference type="DOI" id="10.1172/jci36226"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="48">
    <citation type="journal article" date="2009" name="J. Proteome Res." volume="8" first="651" last="661">
      <title>Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry.</title>
      <authorList>
        <person name="Chen R."/>
        <person name="Jiang X."/>
        <person name="Sun D."/>
        <person name="Han G."/>
        <person name="Wang F."/>
        <person name="Ye M."/>
        <person name="Wang L."/>
        <person name="Zou H."/>
      </authorList>
      <dbReference type="PubMed" id="19159218"/>
      <dbReference type="DOI" id="10.1021/pr8008012"/>
    </citation>
    <scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-497</scope>
    <source>
      <tissue>Liver</tissue>
    </source>
  </reference>
  <reference key="49">
    <citation type="journal article" date="2010" name="FEBS J." volume="277" first="2051" last="2066">
      <title>Human lactoferrin activates NF-kappaB through the Toll-like receptor 4 pathway while it interferes with the lipopolysaccharide-stimulated TLR4 signaling.</title>
      <authorList>
        <person name="Ando K."/>
        <person name="Hasegawa K."/>
        <person name="Shindo K."/>
        <person name="Furusawa T."/>
        <person name="Fujino T."/>
        <person name="Kikugawa K."/>
        <person name="Nakano H."/>
        <person name="Takeuchi O."/>
        <person name="Akira S."/>
        <person name="Akiyama T."/>
        <person name="Gohda J."/>
        <person name="Inoue J."/>
        <person name="Hayakawa M."/>
      </authorList>
      <dbReference type="PubMed" id="20345905"/>
      <dbReference type="DOI" id="10.1111/j.1742-4658.2010.07620.x"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>PTM</scope>
  </reference>
  <reference key="50">
    <citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="19205" last="19218">
      <title>O-GlcNAcylation/phosphorylation cycling at Ser10 controls both transcriptional activity and stability of delta-lactoferrin.</title>
      <authorList>
        <person name="Hardiville S."/>
        <person name="Hoedt E."/>
        <person name="Mariller C."/>
        <person name="Benaissa M."/>
        <person name="Pierce A."/>
      </authorList>
      <dbReference type="PubMed" id="20404350"/>
      <dbReference type="DOI" id="10.1074/jbc.m109.080572"/>
    </citation>
    <scope>GLYCOSYLATION AT SER-10 (ISOFORM DELTALF)</scope>
    <scope>PHOSPHORYLATION AT SER-10 (ISOFORM DELTALF)</scope>
    <scope>UBIQUITINATION AT LYS-379 AND LYS-391 (ISOFORM DELTALF)</scope>
  </reference>
  <reference key="51">
    <citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
      <title>Initial characterization of the human central proteome.</title>
      <authorList>
        <person name="Burkard T.R."/>
        <person name="Planyavsky M."/>
        <person name="Kaupe I."/>
        <person name="Breitwieser F.P."/>
        <person name="Buerckstuemmer T."/>
        <person name="Bennett K.L."/>
        <person name="Superti-Furga G."/>
        <person name="Colinge J."/>
      </authorList>
      <dbReference type="PubMed" id="21269460"/>
      <dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="52">
    <citation type="journal article" date="2012" name="Biochem. Cell Biol." volume="90" first="307" last="319">
      <title>Delta-lactoferrin, an intracellular lactoferrin isoform that acts as a transcription factor.</title>
      <authorList>
        <person name="Mariller C."/>
        <person name="Hardiville S."/>
        <person name="Hoedt E."/>
        <person name="Huvent I."/>
        <person name="Pina-Canseco S."/>
        <person name="Pierce A."/>
      </authorList>
      <dbReference type="PubMed" id="22320386"/>
      <dbReference type="DOI" id="10.1139/o11-070"/>
    </citation>
    <scope>FUNCTION AS A TRANSCRIPTION FACTOR (ISOFORM DELTALF)</scope>
    <scope>DNA-BINDING (ISOFORM DELTALF)</scope>
  </reference>
  <reference key="53">
    <citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
      <title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
      <authorList>
        <person name="Bian Y."/>
        <person name="Song C."/>
        <person name="Cheng K."/>
        <person name="Dong M."/>
        <person name="Wang F."/>
        <person name="Huang J."/>
        <person name="Sun D."/>
        <person name="Wang L."/>
        <person name="Ye M."/>
        <person name="Zou H."/>
      </authorList>
      <dbReference type="PubMed" id="24275569"/>
      <dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Liver</tissue>
    </source>
  </reference>
  <reference key="54">
    <citation type="journal article" date="1989" name="J. Mol. Biol." volume="209" first="711" last="734">
      <title>Structure of human lactoferrin: crystallographic structure analysis and refinement at 2.8-A resolution.</title>
      <authorList>
        <person name="Anderson B.F."/>
        <person name="Baker H.M."/>
        <person name="Norris G.E."/>
        <person name="Rice D.W."/>
        <person name="Baker E.N."/>
      </authorList>
      <dbReference type="PubMed" id="2585506"/>
      <dbReference type="DOI" id="10.1016/0022-2836(89)90602-5"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS)</scope>
    <scope>SEQUENCE REVISION</scope>
  </reference>
  <reference key="55">
    <citation type="journal article" date="1991" name="Acta Crystallogr. B" volume="47" first="998" last="1004">
      <title>Molecular replacement solution of the structure of apolactoferrin, a protein displaying large-scale conformational change.</title>
      <authorList>
        <person name="Norris G.E."/>
        <person name="Anderson B.F."/>
        <person name="Baker E.N."/>
      </authorList>
      <dbReference type="PubMed" id="1772635"/>
      <dbReference type="DOI" id="10.1107/s0108768191008418"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) OF 20-710</scope>
  </reference>
  <reference key="56">
    <citation type="journal article" date="1992" name="Biochemistry" volume="31" first="4527" last="4533">
      <title>Metal substitution in transferrins: the crystal structure of human copper-lactoferrin at 2.1-A resolution.</title>
      <authorList>
        <person name="Smith C.A."/>
        <person name="Anderson B.F."/>
        <person name="Baker H.M."/>
        <person name="Baker E.N."/>
      </authorList>
      <dbReference type="PubMed" id="1581307"/>
      <dbReference type="DOI" id="10.1021/bi00133a020"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 20-710 IN COMPLEX WITH COPPER AND CARBONATE</scope>
    <scope>GLYCOSYLATION AT ASN-156 AND ASN-497</scope>
  </reference>
  <reference key="57">
    <citation type="journal article" date="1993" name="J. Mol. Biol." volume="232" first="1084" last="1100">
      <title>Structure of the recombinant N-terminal lobe of human lactoferrin at 2.0 A resolution.</title>
      <authorList>
        <person name="Day C.L."/>
        <person name="Anderson B.F."/>
        <person name="Tweedie J.W."/>
        <person name="Baker E.N."/>
      </authorList>
      <dbReference type="PubMed" id="8371268"/>
      <dbReference type="DOI" id="10.1006/jmbi.1993.1462"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 21-352 IN COMPLEX WITH IRON AND CARBONATE</scope>
    <scope>DISULFIDE BONDS</scope>
  </reference>
  <reference key="58">
    <citation type="journal article" date="1994" name="Acta Crystallogr. D" volume="50" first="302" last="316">
      <title>Structure of copper- and oxalate-substituted human lactoferrin at 2.0 A resolution.</title>
      <authorList>
        <person name="Smith C.A."/>
        <person name="Anderson B.F."/>
        <person name="Baker H.M."/>
        <person name="Baker E.N."/>
      </authorList>
      <dbReference type="PubMed" id="15299444"/>
      <dbReference type="DOI" id="10.1107/s0907444994000491"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 20-710 IN COMPLEX WITH COPPER AND OXALATE</scope>
    <scope>GLYCOSYLATION AT ASN-156</scope>
  </reference>
  <reference key="59">
    <citation type="journal article" date="1994" name="Structure" volume="2" first="209" last="219">
      <title>Structures of a legume lectin complexed with the human lactotransferrin N2 fragment, and with an isolated biantennary glycopeptide: role of the fucose moiety.</title>
      <authorList>
        <person name="Bourne Y."/>
        <person name="Mazurier J."/>
        <person name="Legrand D."/>
        <person name="Rouge P."/>
        <person name="Montreuil J."/>
        <person name="Spik G."/>
        <person name="Cambillau C."/>
      </authorList>
      <dbReference type="PubMed" id="8069634"/>
      <dbReference type="DOI" id="10.1016/s0969-2126(00)00022-8"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (3.30 ANGSTROMS) OF 110-268</scope>
    <scope>GLYCOSYLATION AT ASN-156</scope>
  </reference>
  <reference key="60">
    <citation type="journal article" date="1995" name="Acta Crystallogr. D" volume="51" first="629" last="646">
      <title>Structure of human diferric lactoferrin refined at 2.2-A resolution.</title>
      <authorList>
        <person name="Haridas M."/>
        <person name="Anderson B.F."/>
        <person name="Baker E.N."/>
      </authorList>
      <dbReference type="PubMed" id="15299793"/>
      <dbReference type="DOI" id="10.1107/s0907444994013521"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 20-710 IN COMPLEX WITH IRON AND CARBONATE</scope>
    <scope>GLYCOSYLATION AT ASN-156 AND ASN-497</scope>
  </reference>
  <reference key="61">
    <citation type="journal article" date="1996" name="Biochemistry" volume="35" first="9007" last="9013">
      <title>Anion binding by transferrins: importance of second-shell effects revealed by the crystal structure of oxalate-substituted diferric lactoferrin.</title>
      <authorList>
        <person name="Baker H.M."/>
        <person name="Anderson B.F."/>
        <person name="Brodie A.M."/>
        <person name="Shongwe M.S."/>
        <person name="Smith C.A."/>
        <person name="Baker E.N."/>
      </authorList>
      <dbReference type="PubMed" id="8703903"/>
      <dbReference type="DOI" id="10.1021/bi960288y"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 20-710 IN COMPLEX WITH IRON AND OXALATE</scope>
  </reference>
  <reference key="62">
    <citation type="journal article" date="1996" name="Biochemistry" volume="35" first="14473" last="14479">
      <title>Mutation of arginine 121 in lactoferrin destabilizes iron binding by disruption of anion binding: crystal structures of R121S and R121E mutants.</title>
      <authorList>
        <person name="Faber H.R."/>
        <person name="Baker C.J."/>
        <person name="Day C.L."/>
        <person name="Tweedie J.W."/>
        <person name="Baker E.N."/>
      </authorList>
      <dbReference type="PubMed" id="8931543"/>
      <dbReference type="DOI" id="10.1021/bi961729g"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 22-352 OF MUTANTS GLU-140 AND SER-140 IN COMPLEX WITH IRON AND CARBONATE</scope>
    <scope>MUTAGENESIS OF ARG-140</scope>
  </reference>
  <reference key="63">
    <citation type="journal article" date="1996" name="J. Mol. Biol." volume="256" first="352" last="363">
      <title>Altered domain closure and iron binding in transferrins: the crystal structure of the Asp60Ser mutant of the amino-terminal half-molecule of human lactoferrin.</title>
      <authorList>
        <person name="Faber H.R."/>
        <person name="Bland T."/>
        <person name="Day C.L."/>
        <person name="Norris G.E."/>
        <person name="Tweedie J.W."/>
        <person name="Baker E.N."/>
      </authorList>
      <dbReference type="PubMed" id="8594202"/>
      <dbReference type="DOI" id="10.1006/jmbi.1996.0091"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) OF 21-352 OF MUTANT SER-79 IN COMPLEX WITH IRON AND CARBONATE</scope>
    <scope>MUTAGENESIS OF ASP-79</scope>
  </reference>
  <reference key="64">
    <citation type="journal article" date="1997" name="Biochemistry" volume="36" first="341" last="346">
      <title>Mutagenesis of the histidine ligand in human lactoferrin: iron binding properties and crystal structure of the histidine-253--&gt;methionine mutant.</title>
      <authorList>
        <person name="Nicholson H."/>
        <person name="Anderson B.F."/>
        <person name="Bland T."/>
        <person name="Shewry S.C."/>
        <person name="Tweedie J.W."/>
        <person name="Baker E.N."/>
      </authorList>
      <dbReference type="PubMed" id="9003186"/>
      <dbReference type="DOI" id="10.1021/bi961908y"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 21-353 OF MUTANT MET-272 IN COMPLEX WITH IRON AND CARBONATE</scope>
    <scope>MUTAGENESIS OF HIS-272</scope>
  </reference>
  <reference key="65">
    <citation type="journal article" date="1998" name="Acta Crystallogr. D" volume="54" first="1319" last="1335">
      <title>Structure of human apolactoferrin at 2.0 A resolution. Refinement and analysis of ligand-induced conformational change.</title>
      <authorList>
        <person name="Jameson G.B."/>
        <person name="Anderson B.F."/>
        <person name="Norris G.E."/>
        <person name="Thomas D.H."/>
        <person name="Baker E.N."/>
      </authorList>
      <dbReference type="PubMed" id="10089508"/>
      <dbReference type="DOI" id="10.1107/s0907444998004417"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 20-710</scope>
  </reference>
  <reference key="66">
    <citation type="journal article" date="1999" name="Acta Crystallogr. D" volume="55" first="403" last="407">
      <title>Structure of recombinant human lactoferrin expressed in Aspergillus awamori.</title>
      <authorList>
        <person name="Sun X.L."/>
        <person name="Baker H.M."/>
        <person name="Shewry S.C."/>
        <person name="Jameson G.B."/>
        <person name="Baker E.N."/>
      </authorList>
      <dbReference type="PubMed" id="10089347"/>
      <dbReference type="DOI" id="10.1107/s0907444998011226"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) 20-710 IN COMPLEX WITH IRON AND CARBONATE</scope>
  </reference>
  <reference key="67">
    <citation type="journal article" date="2000" name="Biochemistry" volume="39" first="6625" last="6633">
      <title>Crystal structure and iron-binding properties of the R210K mutant of the N-lobe of human lactoferrin: implications for iron release from transferrins.</title>
      <authorList>
        <person name="Peterson N.A."/>
        <person name="Anderson B.F."/>
        <person name="Jameson G.B."/>
        <person name="Tweedie J.W."/>
        <person name="Baker E.N."/>
      </authorList>
      <dbReference type="PubMed" id="10828980"/>
      <dbReference type="DOI" id="10.1021/bi0001224"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 21-348 OF MUTANT LYS-229 IN COMPLEX WITH IRON AND CARBONATE</scope>
    <scope>MUTAGENESIS OF ARG-229</scope>
  </reference>
  <reference key="68">
    <citation type="journal article" date="2000" name="J. Biol. Inorg. Chem." volume="5" first="692" last="698">
      <title>Metal substitution in transferrins: specific binding of cerium(IV) revealed by the crystal structure of cerium-substituted human lactoferrin.</title>
      <authorList>
        <person name="Baker H.M."/>
        <person name="Baker C.J."/>
        <person name="Smith C.A."/>
        <person name="Baker E.N."/>
      </authorList>
      <dbReference type="PubMed" id="11128996"/>
      <dbReference type="DOI" id="10.1007/s007750000157"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 21-710 IN COMPLEX WITH CERIUM AND CARBONATE</scope>
  </reference>
  <reference key="69">
    <citation type="journal article" date="2002" name="Acta Crystallogr. D" volume="58" first="955" last="962">
      <title>Structure of a domain-opened mutant (R121D) of the human lactoferrin N-lobe refined from a merohedrally twinned crystal form.</title>
      <authorList>
        <person name="Jameson G.B."/>
        <person name="Anderson B.F."/>
        <person name="Breyer W.A."/>
        <person name="Day C.L."/>
        <person name="Tweedie J.W."/>
        <person name="Baker E.N."/>
      </authorList>
      <dbReference type="PubMed" id="12037297"/>
      <dbReference type="DOI" id="10.1107/s0907444902005127"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (3.00 ANGSTROMS) OF 21-351 OF MUTANT ASP-140</scope>
    <scope>MUTAGENESIS OF ARG-140</scope>
  </reference>
  <reference key="70">
    <citation type="journal article" date="2002" name="Biochemistry" volume="41" first="14167" last="14175">
      <title>'Dilysine trigger' in transferrins probed by mutagenesis of lactoferrin: crystal structures of the R210G, R210E, and R210L mutants of human lactoferrin.</title>
      <authorList>
        <person name="Peterson N.A."/>
        <person name="Arcus V.L."/>
        <person name="Anderson B.F."/>
        <person name="Tweedie J.W."/>
        <person name="Jameson G.B."/>
        <person name="Baker E.N."/>
      </authorList>
      <dbReference type="PubMed" id="12450380"/>
      <dbReference type="DOI" id="10.1021/bi020443a"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 21-352 OF MUTANTS GLY-229; GLU-229 AND LEU-229 IN COMPLEX WITH IRON AND CARBONATE</scope>
    <scope>MUTAGENESIS OF ARG-229</scope>
  </reference>
  <reference key="71">
    <citation type="submission" date="2004-03" db="PDB data bank">
      <title>Structure of human diferric lactoferrin at 2.5A resolution using crystals grown at pH 6.5.</title>
      <authorList>
        <person name="Vikram P."/>
        <person name="Prem Kumar R."/>
        <person name="Singh N."/>
        <person name="Kumar J."/>
        <person name="Ethayathulla A.S."/>
        <person name="Sharma S."/>
        <person name="Kaur P."/>
        <person name="Singh T.P."/>
      </authorList>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 20-710 IN COMPLEX WITH IRON AND CARBONATE</scope>
    <scope>GLYCOSYLATION AT ASN-156 AND ASN-497</scope>
  </reference>
  <reference key="72">
    <citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="16955" last="16961">
      <title>Structural origin of endotoxin neutralization and antimicrobial activity of a lactoferrin-based peptide.</title>
      <authorList>
        <person name="Japelj B."/>
        <person name="Pristovsek P."/>
        <person name="Majerle A."/>
        <person name="Jerala R."/>
      </authorList>
      <dbReference type="PubMed" id="15687491"/>
      <dbReference type="DOI" id="10.1074/jbc.m500266200"/>
    </citation>
    <scope>STRUCTURE BY NMR OF 39-49 IN COMPLEX WITH LIPOPOLYSACCHARIDE</scope>
    <scope>SYNTHESIS OF 39-49</scope>
  </reference>
  <reference key="73">
    <citation type="journal article" date="2005" name="Transgenic Res." volume="14" first="397" last="405">
      <title>The protein structure of recombinant human lactoferrin produced in the milk of transgenic cows closely matches the structure of human milk-derived lactoferrin.</title>
      <authorList>
        <person name="Thomassen E.A."/>
        <person name="van Veen H.A."/>
        <person name="van Berkel P.H."/>
        <person name="Nuijens J.H."/>
        <person name="Abrahams J.P."/>
      </authorList>
      <dbReference type="PubMed" id="16201406"/>
      <dbReference type="DOI" id="10.1007/s11248-005-3233-0"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 20-710 IN COMPLEX WITH IRON AND CARBONATE</scope>
    <scope>GLYCOSYLATION AT ASN-156 AND ASN-497</scope>
    <scope>VARIANT ASP-579</scope>
  </reference>
  <reference key="74">
    <citation type="submission" date="2006-05" db="PDB data bank">
      <title>Crystal structure of the complex formed between proteinase K and a human lactoferrin fragment at 2.9 A resolution.</title>
      <authorList>
        <person name="Singh A.K."/>
        <person name="Singh N."/>
        <person name="Sharma S."/>
        <person name="Bhushan A."/>
        <person name="Singh T.P."/>
      </authorList>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.90 ANGSTROMS) OF 528-535 IN COMPLEX WITH PROTEINASE K</scope>
  </reference>
  <reference key="75">
    <citation type="submission" date="2006-06" db="PDB data bank">
      <title>Crystal structure of proteinase K inhibited by a lactoferrin octapeptide Gly-Asp-Glu-Gln-Gly-Glu-Asn-Lys at 2.15 A resolution.</title>
      <authorList>
        <person name="Prem Kumar R."/>
        <person name="Singh A.K."/>
        <person name="Singh N."/>
        <person name="Kaur P."/>
        <person name="Sharma S."/>
        <person name="Singh T.P."/>
      </authorList>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 528-535 IN COMPLEX WITH PROTEINASE K</scope>
  </reference>
  <reference key="76">
    <citation type="journal article" date="2007" name="J. Am. Chem. Soc." volume="129" first="1022" last="1023">
      <title>The acyl group as the central element of the structural organization of antimicrobial lipopeptide.</title>
      <authorList>
        <person name="Japelj B."/>
        <person name="Zorko M."/>
        <person name="Majerle A."/>
        <person name="Pristovsek P."/>
        <person name="Sanchez-Gomez S."/>
        <person name="Martinez de Tejada G."/>
        <person name="Moriyon I."/>
        <person name="Blondelle S.E."/>
        <person name="Brandenburg K."/>
        <person name="Andra J."/>
        <person name="Lohner K."/>
        <person name="Jerala R."/>
      </authorList>
      <dbReference type="PubMed" id="17263370"/>
      <dbReference type="DOI" id="10.1021/ja067419v"/>
    </citation>
    <scope>STRUCTURE BY NMR OF 39-49</scope>
  </reference>
  <reference key="77">
    <citation type="journal article" date="2007" name="J. Mol. Biol." volume="370" first="701" last="713">
      <title>Structure of a complex of human lactoferrin N-lobe with pneumococcal surface protein a provides insight into microbial defense mechanism.</title>
      <authorList>
        <person name="Senkovich O."/>
        <person name="Cook W.J."/>
        <person name="Mirza S."/>
        <person name="Hollingshead S.K."/>
        <person name="Protasevich I.I."/>
        <person name="Briles D.E."/>
        <person name="Chattopadhyay D."/>
      </authorList>
      <dbReference type="PubMed" id="17543335"/>
      <dbReference type="DOI" id="10.1016/j.jmb.2007.04.075"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.91 ANGSTROMS) OF 21-362 IN COMPLEX WITH PNEUMOCOCCAL SURFACE PROTEIN A FRAGMENT; IRON AND CARBONATE</scope>
  </reference>
  <reference key="78">
    <citation type="journal article" date="1998" name="Mol. Vis." volume="4" first="31" last="32">
      <title>Familial subepithelial corneal amyloidosis (gelatinous drop-like corneal dystrophy): exclusion of linkage to lactoferrin gene.</title>
      <authorList>
        <person name="Klintworth G.K."/>
        <person name="Sommer J.R."/>
        <person name="Obrian G."/>
        <person name="Han L."/>
        <person name="Ahmed M.N."/>
        <person name="Qumsiyeh M.B."/>
        <person name="Lin P.-Y."/>
        <person name="Basti S."/>
        <person name="Reddy M.K."/>
        <person name="Kanai A."/>
        <person name="Hotta Y."/>
        <person name="Sugar J."/>
        <person name="Kumaramanickavel G."/>
        <person name="Munier F."/>
        <person name="Schorderet D.F."/>
        <person name="El Matri L."/>
        <person name="Iwata F."/>
        <person name="Kaiser-Kupfer M."/>
        <person name="Nagata M."/>
        <person name="Nakayasu K."/>
        <person name="Hejtmancik J.F."/>
        <person name="Teng C.T."/>
      </authorList>
      <dbReference type="PubMed" id="9873069"/>
    </citation>
    <scope>VARIANTS THR-29 AND ARG-47</scope>
  </reference>
  <reference key="79">
    <citation type="journal article" date="2012" name="Hum. Immunol." volume="73" first="554" last="559">
      <title>Functional polymorphisms in the LTF gene and risk of coronary artery stenosis.</title>
      <authorList>
        <person name="Videm V."/>
        <person name="Dahl H."/>
        <person name="Walberg L.E."/>
        <person name="Wiseth R."/>
      </authorList>
      <dbReference type="PubMed" id="22406253"/>
      <dbReference type="DOI" id="10.1016/j.humimm.2012.02.014"/>
    </citation>
    <scope>VARIANTS ARG-22 INS AND ARG-47</scope>
  </reference>
  <comment type="function">
    <text evidence="39">Transferrins are iron binding transport proteins which can bind two Fe(3+) ions in association with the binding of an anion, usually bicarbonate.</text>
  </comment>
  <comment type="function">
    <molecule>Lactotransferrin</molecule>
    <text evidence="5 7 10 13 15 17 24 27 28 29 33 35 44 45 53">Major iron-binding and multifunctional protein found in exocrine fluids such as breast milk and mucosal secretions (PubMed:14573629, PubMed:1599934, PubMed:6802759, PubMed:3169987, PubMed:11179314, PubMed:12693969). Has antimicrobial activity, which depends on the extracellular cation concentration (PubMed:6802759). Antimicrobial properties include bacteriostasis, which is related to its ability to sequester free iron and thus inhibit microbial growth, as well as direct bactericidal properties leading to the release of lipopolysaccharides from the bacterial outer membrane (PubMed:14573629, PubMed:1599934, PubMed:6802759, PubMed:3169987, PubMed:11179314, PubMed:12693969). Can also prevent bacterial biofilm development in P.aeruginosa infection (PubMed:12037568). Has weak antifungal activity against C.albicans (PubMed:11083624). Has anabolic, differentiating and anti-apoptotic effects on osteoblasts and can also inhibit osteoclastogenesis, possibly playing a role in the regulation of bone growth (PubMed:15166119). Promotes binding of species C adenoviruses to epithelial cells, promoting adenovirus infection (PubMed:17079302). Can inhibit papillomavirus infections (PubMed:17481742). Stimulates the TLR4 signaling pathway leading to NF-kappa-B activation and subsequent pro-inflammatory cytokine production while also interfering with the lipopolysaccharide (LPS)-stimulated TLR4 signaling (PubMed:20345905). Inhibits neutrophil granulocyte migration to sites of apoptosis, when secreted by apoptotic cells (PubMed:19033648). Stimulates VEGFA-mediated endothelial cell migration and proliferation (PubMed:16842782). Binds heparin, chondroitin sulfate and possibly other glycosaminoglycans (GAGs) (PubMed:9359845). Also binds specifically to pneumococcal surface protein A (PspA), the lipid A portion of bacterial lipopolysaccharide (LPS), lysozyme and DNA (PubMed:9359845).</text>
  </comment>
  <comment type="function">
    <text evidence="5 29">Lactoferricin binds to the bacterial surface and is crucial for the bactericidal functions. Has some antiviral activity against papillomavirus infection (PubMed:17481742). N-terminal region shows strong antifungal activity against C.albicans (PubMed:11083624). Contains two BBXB heparin-binding consensus sequences that appear to form the predominate functional GAG-binding site.</text>
  </comment>
  <comment type="function">
    <molecule>Kaliocin-1</molecule>
    <text evidence="13">Has antimicrobial activity and is able to permeabilize different ions through liposomal membranes.</text>
  </comment>
  <comment type="function">
    <molecule>Lactoferroxin-A</molecule>
    <text evidence="14">Has opioid antagonist activity (PubMed:1369293). Shows preference for mu-receptor (PubMed:1369293).</text>
  </comment>
  <comment type="function">
    <molecule>Lactoferroxin-B</molecule>
    <text evidence="14">Has opioid antagonist activity (PubMed:1369293). Shows higher degrees of preference for kappa-receptors than for mu-receptors (PubMed:1369293).</text>
  </comment>
  <comment type="function">
    <molecule>Lactoferroxin-C</molecule>
    <text evidence="14">Has opioid antagonist activity (PubMed:1369293). Shows higher degrees of preference for kappa-receptors than for mu-receptors (PubMed:1369293).</text>
  </comment>
  <comment type="function">
    <text evidence="12">The lactotransferrin transferrin-like domain 1 functions as a serine protease of the peptidase S60 family that cuts arginine rich regions (PubMed:12535064). This function contributes to the antimicrobial activity (PubMed:12535064). Shows a preferential cleavage at -Arg-Ser-Arg-Arg-|- and -Arg-Arg-Ser-Arg-|-, and of Z-Phe-Arg-|-aminomethylcoumarin sites (PubMed:12535064).</text>
  </comment>
  <comment type="function">
    <molecule>Isoform DeltaLf</molecule>
    <text evidence="18 37">Transcription factor with antiproliferative properties and ability to induce cell cycle arrest (PubMed:15222485). Binds to the DeltaLf response element found in the SKP1, BAX, DCPS, and SELENOH promoters (PubMed:22320386).</text>
  </comment>
  <comment type="subunit">
    <text evidence="2 4 6 11 19 20 22 23 26 30 31 39 47 48 49 50 51 60 61 62">Monomer. Found in a complex with LTF, CLU, EPPIN and SEMG1.</text>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1058602">
      <id>P02788</id>
    </interactant>
    <interactant intactId="EBI-397403">
      <id>P62157</id>
      <label>CALM</label>
    </interactant>
    <organismsDiffer>true</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1058602">
      <id>P02788</id>
    </interactant>
    <interactant intactId="EBI-2259469">
      <id>P75358</id>
      <label>gapA</label>
    </interactant>
    <organismsDiffer>true</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1058602">
      <id>P02788</id>
    </interactant>
    <interactant intactId="EBI-2259629">
      <id>P75390</id>
      <label>pdhA</label>
    </interactant>
    <organismsDiffer>true</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1058602">
      <id>P02788</id>
    </interactant>
    <interactant intactId="EBI-2259621">
      <id>P75391</id>
      <label>pdhB</label>
    </interactant>
    <organismsDiffer>true</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1058602">
      <id>P02788</id>
    </interactant>
    <interactant intactId="EBI-2259593">
      <id>P75392</id>
      <label>pdhC</label>
    </interactant>
    <organismsDiffer>true</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1058602">
      <id>P02788</id>
    </interactant>
    <interactant intactId="EBI-2259473">
      <id>P78031</id>
      <label>pyk</label>
    </interactant>
    <organismsDiffer>true</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1058602">
      <id>P02788</id>
    </interactant>
    <interactant intactId="EBI-6904259">
      <id>PRO_0000037569</id>
      <dbReference type="UniProtKB" id="P27958"/>
    </interactant>
    <organismsDiffer>true</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1058602">
      <id>P02788</id>
    </interactant>
    <interactant intactId="EBI-6904269">
      <id>PRO_0000037570</id>
      <dbReference type="UniProtKB" id="P27958"/>
    </interactant>
    <organismsDiffer>true</organismsDiffer>
    <experiments>9</experiments>
  </comment>
  <comment type="subcellular location">
    <molecule>Isoform 1</molecule>
    <subcellularLocation>
      <location>Secreted</location>
    </subcellularLocation>
    <subcellularLocation>
      <location>Cytoplasmic granule</location>
    </subcellularLocation>
    <text>Secreted into most exocrine fluids by various endothelial cells. Stored in the secondary granules of neutrophils.</text>
  </comment>
  <comment type="subcellular location">
    <molecule>Isoform DeltaLf</molecule>
    <subcellularLocation>
      <location>Cytoplasm</location>
    </subcellularLocation>
    <subcellularLocation>
      <location>Nucleus</location>
    </subcellularLocation>
    <text>Mainly localized in the cytoplasm.</text>
  </comment>
  <comment type="alternative products">
    <event type="alternative promoter"/>
    <isoform>
      <id>P02788-1</id>
      <name>1</name>
      <sequence type="displayed"/>
    </isoform>
    <isoform>
      <id>P02788-2</id>
      <name>DeltaLf</name>
      <name>Delta-lactoferrin</name>
      <sequence type="described" ref="VSP_044308"/>
    </isoform>
  </comment>
  <comment type="tissue specificity">
    <text evidence="3 43 52">High levels are found in saliva and tears, intermediate levels in serum and plasma, and low levels in urine. In kidney, detected in the distal collecting tubules in the medulla but not in the cortical region or in blood vessels. Detected in peripheral blood neutrophils (at protein level). Isoform 1 and isoform DeltaLf are expressed in breast, prostate, spleen, pancreas, kidney, small intestine, lung, skeletal muscle, uterus, thymus and fetal liver. Isoform 1 is expressed in brain, testis and peripheral blood leukocytes; isoform DeltaLf is barely detectable in these tissues. Isoform DeltaLf is expressed in placenta, liver and ovary; isoform 1 is barely detectable in these tissues. In kidney, isoform 1 is expressed at high levels in the collecting tubules of the medulla but at very low levels in the cortex.</text>
  </comment>
  <comment type="PTM">
    <molecule>Isoform DeltaLf</molecule>
    <text evidence="36">Phosphorylation at Ser-10 activates the transcriptional activity (PubMed:20404350). Phosphorylation at Ser-10 also promotes proteasomal degradation (PubMed:20404350). Alternatively can undergo O-GlcNAcylation at Ser-10 (PubMed:20404350).</text>
  </comment>
  <comment type="PTM">
    <molecule>Isoform DeltaLf</molecule>
    <text evidence="36">O-GlcNAcylation at Ser-10 inhibits DNA binding and negatively regulates the transcriptional activity (PubMed:20404350). Alternatively can undergo phosphorylation at Ser-10 (PubMed:20404350).</text>
  </comment>
  <comment type="PTM">
    <text>Poly-N-acetyllactosaminic carbohydrate moiety seems to be needed for TLR4 activation.</text>
  </comment>
  <comment type="mass spectrometry" mass="5737.8" method="Electrospray" evidence="25">
    <molecule>Lactoferricin-H</molecule>
  </comment>
  <comment type="polymorphism">
    <text>The sequence shown corresponds to the reference genome sequence and is likely to represent the minor allele, whereas most publications refer to the longer sequence containing variant Arg-22 ins. Insertion of the additional arginine in variant Arg-22 ins creates an N-terminal basic cluster of four arginines, all of which appear to be important for the full functionality of the protein, including bactericidal and antifungal activities as well as binding to glycosaminoglycans, pspA, LPS, lysozyme and DNA.</text>
  </comment>
  <comment type="miscellaneous">
    <molecule>Isoform DeltaLf</molecule>
    <text evidence="67">Contains a phosphoserine at position 10 (alternate). Contains a O-linked (GlcNAc) serine at position 10 (alternate). O-GlcNAcylation at Ser-10 inhibits DNA binding and negatively regulates DeltaLf transcriptional activity, whereas phosphorylation activates it. Phosphorylation at Ser-10 also promotes proteasomal degradation.</text>
  </comment>
  <comment type="similarity">
    <text evidence="1">Belongs to the transferrin family.</text>
  </comment>
  <comment type="online information" name="Wikipedia">
    <link uri="https://en.wikipedia.org/wiki/Lactotransferrin"/>
    <text>Lactotransferrin entry</text>
  </comment>
  <dbReference type="EC" id="3.4.21.-" evidence="12"/>
  <dbReference type="EMBL" id="X53961">
    <property type="protein sequence ID" value="CAA37914.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U07643">
    <property type="protein sequence ID" value="AAB60324.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AF332168">
    <property type="protein sequence ID" value="AAG48753.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AY178998">
    <property type="protein sequence ID" value="AAN75578.2"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AY137470">
    <property type="protein sequence ID" value="AAN11304.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M73700">
    <property type="protein sequence ID" value="AAA59479.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M93150">
    <property type="protein sequence ID" value="AAA36159.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AY165046">
    <property type="protein sequence ID" value="AAN63998.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AY493417">
    <property type="protein sequence ID" value="AAS72878.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="EU622050">
    <property type="protein sequence ID" value="ACC95966.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AK292813">
    <property type="protein sequence ID" value="BAF85502.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AK298035">
    <property type="protein sequence ID" value="BAH12708.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AC098613">
    <property type="status" value="NOT_ANNOTATED_CDS"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BC015822">
    <property type="protein sequence ID" value="AAH15822.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BC015823">
    <property type="protein sequence ID" value="AAH15823.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BC022347">
    <property type="protein sequence ID" value="AAH22347.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="S52659">
    <property type="protein sequence ID" value="AAB24877.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="X52941">
    <property type="protein sequence ID" value="CAA37116.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M83202">
    <property type="protein sequence ID" value="AAA59511.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M83205">
    <property type="protein sequence ID" value="AAA58656.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U95626">
    <property type="protein sequence ID" value="AAB57795.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M18642">
    <property type="protein sequence ID" value="AAA86665.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="CCDS" id="CCDS33747.1">
    <molecule id="P02788-1"/>
  </dbReference>
  <dbReference type="CCDS" id="CCDS56251.1">
    <molecule id="P02788-2"/>
  </dbReference>
  <dbReference type="PIR" id="G01394">
    <property type="entry name" value="TFHUL"/>
  </dbReference>
  <dbReference type="RefSeq" id="NP_001186078.1">
    <molecule id="P02788-2"/>
    <property type="nucleotide sequence ID" value="NM_001199149.1"/>
  </dbReference>
  <dbReference type="RefSeq" id="NP_001308050.1">
    <property type="nucleotide sequence ID" value="NM_001321121.1"/>
  </dbReference>
  <dbReference type="RefSeq" id="NP_001308051.1">
    <property type="nucleotide sequence ID" value="NM_001321122.1"/>
  </dbReference>
  <dbReference type="RefSeq" id="NP_002334.2">
    <molecule id="P02788-1"/>
    <property type="nucleotide sequence ID" value="NM_002343.5"/>
  </dbReference>
  <dbReference type="PDB" id="1B0L">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.20 A"/>
    <property type="chains" value="A=20-710"/>
  </dbReference>
  <dbReference type="PDB" id="1BKA">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.40 A"/>
    <property type="chains" value="A=20-710"/>
  </dbReference>
  <dbReference type="PDB" id="1CB6">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.00 A"/>
    <property type="chains" value="A=20-710"/>
  </dbReference>
  <dbReference type="PDB" id="1DSN">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.05 A"/>
    <property type="chains" value="A=21-352"/>
  </dbReference>
  <dbReference type="PDB" id="1EH3">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.00 A"/>
    <property type="chains" value="A=21-352"/>
  </dbReference>
  <dbReference type="PDB" id="1FCK">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.20 A"/>
    <property type="chains" value="A=21-710"/>
  </dbReference>
  <dbReference type="PDB" id="1H43">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.20 A"/>
    <property type="chains" value="A=21-352"/>
  </dbReference>
  <dbReference type="PDB" id="1H44">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.00 A"/>
    <property type="chains" value="A=21-352"/>
  </dbReference>
  <dbReference type="PDB" id="1H45">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.95 A"/>
    <property type="chains" value="A=21-352"/>
  </dbReference>
  <dbReference type="PDB" id="1HSE">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.20 A"/>
    <property type="chains" value="A=21-353"/>
  </dbReference>
  <dbReference type="PDB" id="1L5T">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.00 A"/>
    <property type="chains" value="A/B=21-351"/>
  </dbReference>
  <dbReference type="PDB" id="1LCF">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.00 A"/>
    <property type="chains" value="A=20-710"/>
  </dbReference>
  <dbReference type="PDB" id="1LCT">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.00 A"/>
    <property type="chains" value="A=21-352"/>
  </dbReference>
  <dbReference type="PDB" id="1LFG">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.20 A"/>
    <property type="chains" value="A=20-710"/>
  </dbReference>
  <dbReference type="PDB" id="1LFH">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.80 A"/>
    <property type="chains" value="A=20-710"/>
  </dbReference>
  <dbReference type="PDB" id="1LFI">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.10 A"/>
    <property type="chains" value="A=20-710"/>
  </dbReference>
  <dbReference type="PDB" id="1LGB">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.30 A"/>
    <property type="chains" value="C=110-268"/>
  </dbReference>
  <dbReference type="PDB" id="1N76">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.40 A"/>
    <property type="chains" value="A=21-710"/>
  </dbReference>
  <dbReference type="PDB" id="1SQY">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.50 A"/>
    <property type="chains" value="A=20-710"/>
  </dbReference>
  <dbReference type="PDB" id="1U62">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=39-49"/>
  </dbReference>
  <dbReference type="PDB" id="1VFD">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.50 A"/>
    <property type="chains" value="A=20-349"/>
  </dbReference>
  <dbReference type="PDB" id="1VFE">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.30 A"/>
    <property type="chains" value="A=20-352"/>
  </dbReference>
  <dbReference type="PDB" id="1XV4">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=39-49"/>
  </dbReference>
  <dbReference type="PDB" id="1XV7">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=39-49"/>
  </dbReference>
  <dbReference type="PDB" id="1Z6V">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=21-67"/>
  </dbReference>
  <dbReference type="PDB" id="1Z6W">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=21-67"/>
  </dbReference>
  <dbReference type="PDB" id="2BJJ">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.40 A"/>
    <property type="chains" value="X=21-710"/>
  </dbReference>
  <dbReference type="PDB" id="2DP4">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.90 A"/>
    <property type="chains" value="I=528-535"/>
  </dbReference>
  <dbReference type="PDB" id="2GMC">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=39-49"/>
  </dbReference>
  <dbReference type="PDB" id="2GMD">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=39-49"/>
  </dbReference>
  <dbReference type="PDB" id="2HD4">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.15 A"/>
    <property type="chains" value="B=528-535"/>
  </dbReference>
  <dbReference type="PDB" id="2PMS">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.91 A"/>
    <property type="chains" value="A/B=21-362"/>
  </dbReference>
  <dbReference type="PDB" id="7JRD">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.85 A"/>
    <property type="chains" value="B=21-710"/>
  </dbReference>
  <dbReference type="PDB" id="7N88">
    <property type="method" value="EM"/>
    <property type="resolution" value="3.70 A"/>
    <property type="chains" value="B=20-710"/>
  </dbReference>
  <dbReference type="PDBsum" id="1B0L"/>
  <dbReference type="PDBsum" id="1BKA"/>
  <dbReference type="PDBsum" id="1CB6"/>
  <dbReference type="PDBsum" id="1DSN"/>
  <dbReference type="PDBsum" id="1EH3"/>
  <dbReference type="PDBsum" id="1FCK"/>
  <dbReference type="PDBsum" id="1H43"/>
  <dbReference type="PDBsum" id="1H44"/>
  <dbReference type="PDBsum" id="1H45"/>
  <dbReference type="PDBsum" id="1HSE"/>
  <dbReference type="PDBsum" id="1L5T"/>
  <dbReference type="PDBsum" id="1LCF"/>
  <dbReference type="PDBsum" id="1LCT"/>
  <dbReference type="PDBsum" id="1LFG"/>
  <dbReference type="PDBsum" id="1LFH"/>
  <dbReference type="PDBsum" id="1LFI"/>
  <dbReference type="PDBsum" id="1LGB"/>
  <dbReference type="PDBsum" id="1N76"/>
  <dbReference type="PDBsum" id="1SQY"/>
  <dbReference type="PDBsum" id="1U62"/>
  <dbReference type="PDBsum" id="1VFD"/>
  <dbReference type="PDBsum" id="1VFE"/>
  <dbReference type="PDBsum" id="1XV4"/>
  <dbReference type="PDBsum" id="1XV7"/>
  <dbReference type="PDBsum" id="1Z6V"/>
  <dbReference type="PDBsum" id="1Z6W"/>
  <dbReference type="PDBsum" id="2BJJ"/>
  <dbReference type="PDBsum" id="2DP4"/>
  <dbReference type="PDBsum" id="2GMC"/>
  <dbReference type="PDBsum" id="2GMD"/>
  <dbReference type="PDBsum" id="2HD4"/>
  <dbReference type="PDBsum" id="2PMS"/>
  <dbReference type="PDBsum" id="7JRD"/>
  <dbReference type="PDBsum" id="7N88"/>
  <dbReference type="AlphaFoldDB" id="P02788"/>
  <dbReference type="SASBDB" id="P02788"/>
  <dbReference type="SMR" id="P02788"/>
  <dbReference type="BioGRID" id="110235">
    <property type="interactions" value="162"/>
  </dbReference>
  <dbReference type="CORUM" id="P02788"/>
  <dbReference type="DIP" id="DIP-41354N"/>
  <dbReference type="IntAct" id="P02788">
    <property type="interactions" value="53"/>
  </dbReference>
  <dbReference type="MINT" id="P02788"/>
  <dbReference type="STRING" id="9606.ENSP00000231751"/>
  <dbReference type="ChEMBL" id="CHEMBL4523161"/>
  <dbReference type="DrugBank" id="DB06987">
    <property type="generic name" value="(R)-Atenolol"/>
  </dbReference>
  <dbReference type="DrugBank" id="DB01811">
    <property type="generic name" value="3h-Indole-5,6-Diol"/>
  </dbReference>
  <dbReference type="DrugBank" id="DB03485">
    <property type="generic name" value="alpha-D-Fucopyranose"/>
  </dbReference>
  <dbReference type="DrugBank" id="DB06784">
    <property type="generic name" value="Gallium citrate Ga-67"/>
  </dbReference>
  <dbReference type="DrugBank" id="DB03017">
    <property type="generic name" value="Lauric acid"/>
  </dbReference>
  <dbReference type="DrugBank" id="DB04743">
    <property type="generic name" value="Nimesulide"/>
  </dbReference>
  <dbReference type="DrugBank" id="DB03040">
    <property type="generic name" value="Nitrilotriacetic acid"/>
  </dbReference>
  <dbReference type="DrugBank" id="DB08439">
    <property type="generic name" value="Parecoxib"/>
  </dbReference>
  <dbReference type="DrugBank" id="DB11182">
    <property type="generic name" value="Rose bengal"/>
  </dbReference>
  <dbReference type="Allergome" id="1384">
    <property type="allergen name" value="Hom s LF"/>
  </dbReference>
  <dbReference type="MEROPS" id="S60.001"/>
  <dbReference type="MEROPS" id="S60.970"/>
  <dbReference type="GlyConnect" id="2842">
    <property type="glycosylation" value="5 N-Linked glycans"/>
  </dbReference>
  <dbReference type="GlyConnect" id="320">
    <property type="glycosylation" value="168 N-Linked glycans (3 sites), 2 O-Linked glycans (1 site)"/>
  </dbReference>
  <dbReference type="GlyCosmos" id="P02788">
    <property type="glycosylation" value="6 sites, 161 glycans"/>
  </dbReference>
  <dbReference type="GlyGen" id="P02788">
    <property type="glycosylation" value="5 sites, 158 N-linked glycans (4 sites), 2 O-linked glycans (1 site)"/>
  </dbReference>
  <dbReference type="iPTMnet" id="P02788"/>
  <dbReference type="PhosphoSitePlus" id="P02788"/>
  <dbReference type="BioMuta" id="LTF"/>
  <dbReference type="DMDM" id="85700158"/>
  <dbReference type="EPD" id="P02788"/>
  <dbReference type="jPOST" id="P02788"/>
  <dbReference type="MassIVE" id="P02788"/>
  <dbReference type="PaxDb" id="P02788"/>
  <dbReference type="PeptideAtlas" id="P02788"/>
  <dbReference type="PRIDE" id="P02788"/>
  <dbReference type="ProteomicsDB" id="51597">
    <molecule id="P02788-1"/>
  </dbReference>
  <dbReference type="ProteomicsDB" id="6642"/>
  <dbReference type="Antibodypedia" id="3271">
    <property type="antibodies" value="1452 antibodies from 44 providers"/>
  </dbReference>
  <dbReference type="DNASU" id="4057"/>
  <dbReference type="Ensembl" id="ENST00000231751.9">
    <molecule id="P02788-1"/>
    <property type="protein sequence ID" value="ENSP00000231751.4"/>
    <property type="gene ID" value="ENSG00000012223.13"/>
  </dbReference>
  <dbReference type="Ensembl" id="ENST00000426532.6">
    <molecule id="P02788-2"/>
    <property type="protein sequence ID" value="ENSP00000405719.2"/>
    <property type="gene ID" value="ENSG00000012223.13"/>
  </dbReference>
  <dbReference type="GeneID" id="4057"/>
  <dbReference type="KEGG" id="hsa:4057"/>
  <dbReference type="MANE-Select" id="ENST00000231751.9">
    <property type="protein sequence ID" value="ENSP00000231751.4"/>
    <property type="RefSeq nucleotide sequence ID" value="NM_002343.6"/>
    <property type="RefSeq protein sequence ID" value="NP_002334.2"/>
  </dbReference>
  <dbReference type="UCSC" id="uc003fzr.4">
    <molecule id="P02788-1"/>
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="AGR" id="HGNC:6720"/>
  <dbReference type="CTD" id="4057"/>
  <dbReference type="DisGeNET" id="4057"/>
  <dbReference type="GeneCards" id="LTF"/>
  <dbReference type="HGNC" id="HGNC:6720">
    <property type="gene designation" value="LTF"/>
  </dbReference>
  <dbReference type="HPA" id="ENSG00000012223">
    <property type="expression patterns" value="Group enriched (bone marrow, salivary gland)"/>
  </dbReference>
  <dbReference type="MIM" id="150210">
    <property type="type" value="gene"/>
  </dbReference>
  <dbReference type="neXtProt" id="NX_P02788"/>
  <dbReference type="OpenTargets" id="ENSG00000012223"/>
  <dbReference type="PharmGKB" id="PA30482"/>
  <dbReference type="VEuPathDB" id="HostDB:ENSG00000012223"/>
  <dbReference type="eggNOG" id="ENOG502QT0C">
    <property type="taxonomic scope" value="Eukaryota"/>
  </dbReference>
  <dbReference type="GeneTree" id="ENSGT00940000156055"/>
  <dbReference type="HOGENOM" id="CLU_011309_1_0_1"/>
  <dbReference type="InParanoid" id="P02788"/>
  <dbReference type="OMA" id="EAQPRTH"/>
  <dbReference type="OrthoDB" id="2906687at2759"/>
  <dbReference type="PhylomeDB" id="P02788"/>
  <dbReference type="TreeFam" id="TF324013"/>
  <dbReference type="PathwayCommons" id="P02788"/>
  <dbReference type="Reactome" id="R-HSA-1222449">
    <property type="pathway name" value="Mtb iron assimilation by chelation"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-6798695">
    <property type="pathway name" value="Neutrophil degranulation"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-6799990">
    <property type="pathway name" value="Metal sequestration by antimicrobial proteins"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-6803157">
    <property type="pathway name" value="Antimicrobial peptides"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-977225">
    <property type="pathway name" value="Amyloid fiber formation"/>
  </dbReference>
  <dbReference type="SignaLink" id="P02788"/>
  <dbReference type="SIGNOR" id="P02788"/>
  <dbReference type="BioGRID-ORCS" id="4057">
    <property type="hits" value="47 hits in 1161 CRISPR screens"/>
  </dbReference>
  <dbReference type="ChiTaRS" id="LTF">
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="EvolutionaryTrace" id="P02788"/>
  <dbReference type="GeneWiki" id="Lactoferrin"/>
  <dbReference type="GenomeRNAi" id="4057"/>
  <dbReference type="Pharos" id="P02788">
    <property type="development level" value="Tbio"/>
  </dbReference>
  <dbReference type="PRO" id="PR:P02788"/>
  <dbReference type="Proteomes" id="UP000005640">
    <property type="component" value="Chromosome 3"/>
  </dbReference>
  <dbReference type="RNAct" id="P02788">
    <property type="molecule type" value="Protein"/>
  </dbReference>
  <dbReference type="Bgee" id="ENSG00000012223">
    <property type="expression patterns" value="Expressed in trachea and 142 other tissues"/>
  </dbReference>
  <dbReference type="ExpressionAtlas" id="P02788">
    <property type="expression patterns" value="baseline and differential"/>
  </dbReference>
  <dbReference type="Genevisible" id="P02788">
    <property type="organism ID" value="HS"/>
  </dbReference>
  <dbReference type="GO" id="GO:0009986">
    <property type="term" value="C:cell surface"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005737">
    <property type="term" value="C:cytoplasm"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="AgBase"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005769">
    <property type="term" value="C:early endosome"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0070062">
    <property type="term" value="C:extracellular exosome"/>
    <property type="evidence" value="ECO:0007005"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005576">
    <property type="term" value="C:extracellular region"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="Reactome"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005615">
    <property type="term" value="C:extracellular space"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005634">
    <property type="term" value="C:nucleus"/>
    <property type="evidence" value="ECO:0007005"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0097013">
    <property type="term" value="C:phagocytic vesicle lumen"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="Reactome"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005886">
    <property type="term" value="C:plasma membrane"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0032991">
    <property type="term" value="C:protein-containing complex"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0055037">
    <property type="term" value="C:recycling endosome"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0030141">
    <property type="term" value="C:secretory granule"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="MGI"/>
  </dbReference>
  <dbReference type="GO" id="GO:0042581">
    <property type="term" value="C:specific granule"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0035580">
    <property type="term" value="C:specific granule lumen"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="Reactome"/>
  </dbReference>
  <dbReference type="GO" id="GO:1904724">
    <property type="term" value="C:tertiary granule lumen"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="Reactome"/>
  </dbReference>
  <dbReference type="GO" id="GO:0004869">
    <property type="term" value="F:cysteine-type endopeptidase inhibitor activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="CAFA"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003677">
    <property type="term" value="F:DNA binding"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-KW"/>
  </dbReference>
  <dbReference type="GO" id="GO:0008201">
    <property type="term" value="F:heparin binding"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="MGI"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005506">
    <property type="term" value="F:iron ion binding"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0001530">
    <property type="term" value="F:lipopolysaccharide binding"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0140912">
    <property type="term" value="F:membrane destabilizing activity"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0043539">
    <property type="term" value="F:protein serine/threonine kinase activator activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0004252">
    <property type="term" value="F:serine-type endopeptidase activity"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="ProtInc"/>
  </dbReference>
  <dbReference type="GO" id="GO:0019731">
    <property type="term" value="P:antibacterial humoral response"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0019732">
    <property type="term" value="P:antifungal humoral response"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0061844">
    <property type="term" value="P:antimicrobial humoral immune response mediated by antimicrobial peptide"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0060349">
    <property type="term" value="P:bone morphogenesis"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0051838">
    <property type="term" value="P:cytolysis by host of symbiont cells"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0050829">
    <property type="term" value="P:defense response to Gram-negative bacterium"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0050830">
    <property type="term" value="P:defense response to Gram-positive bacterium"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0006959">
    <property type="term" value="P:humoral immune response"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="ProtInc"/>
  </dbReference>
  <dbReference type="GO" id="GO:0045087">
    <property type="term" value="P:innate immune response"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0002227">
    <property type="term" value="P:innate immune response in mucosa"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0034755">
    <property type="term" value="P:iron ion transmembrane transport"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-KW"/>
  </dbReference>
  <dbReference type="GO" id="GO:0006826">
    <property type="term" value="P:iron ion transport"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0031640">
    <property type="term" value="P:killing of cells of another organism"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0044793">
    <property type="term" value="P:negative regulation by host of viral process"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="AgBase"/>
  </dbReference>
  <dbReference type="GO" id="GO:0043066">
    <property type="term" value="P:negative regulation of apoptotic process"/>
    <property type="evidence" value="ECO:0000250"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0032780">
    <property type="term" value="P:negative regulation of ATP-dependent activity"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="AgBase"/>
  </dbReference>
  <dbReference type="GO" id="GO:2000117">
    <property type="term" value="P:negative regulation of cysteine-type endopeptidase activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="CAFA"/>
  </dbReference>
  <dbReference type="GO" id="GO:0031665">
    <property type="term" value="P:negative regulation of lipopolysaccharide-mediated signaling pathway"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0045837">
    <property type="term" value="P:negative regulation of membrane potential"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:2001205">
    <property type="term" value="P:negative regulation of osteoclast development"/>
    <property type="evidence" value="ECO:0000250"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:1900229">
    <property type="term" value="P:negative regulation of single-species biofilm formation in or on host organism"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:2000308">
    <property type="term" value="P:negative regulation of tumor necrosis factor (ligand) superfamily member 11 production"/>
    <property type="evidence" value="ECO:0000250"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0045071">
    <property type="term" value="P:negative regulation of viral genome replication"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="AgBase"/>
  </dbReference>
  <dbReference type="GO" id="GO:0048525">
    <property type="term" value="P:negative regulation of viral process"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="AgBase"/>
  </dbReference>
  <dbReference type="GO" id="GO:0001503">
    <property type="term" value="P:ossification"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-KW"/>
  </dbReference>
  <dbReference type="GO" id="GO:1900159">
    <property type="term" value="P:positive regulation of bone mineralization involved in bone maturation"/>
    <property type="evidence" value="ECO:0000250"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:1902732">
    <property type="term" value="P:positive regulation of chondrocyte proliferation"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0043123">
    <property type="term" value="P:positive regulation of I-kappaB kinase/NF-kappaB signaling"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0051092">
    <property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0045669">
    <property type="term" value="P:positive regulation of osteoblast differentiation"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0033690">
    <property type="term" value="P:positive regulation of osteoblast proliferation"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0071902">
    <property type="term" value="P:positive regulation of protein serine/threonine kinase activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0034145">
    <property type="term" value="P:positive regulation of toll-like receptor 4 signaling pathway"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0006508">
    <property type="term" value="P:proteolysis"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-KW"/>
  </dbReference>
  <dbReference type="GO" id="GO:0001817">
    <property type="term" value="P:regulation of cytokine production"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0032680">
    <property type="term" value="P:regulation of tumor necrosis factor production"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0001895">
    <property type="term" value="P:retina homeostasis"/>
    <property type="evidence" value="ECO:0007007"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="CDD" id="cd13617">
    <property type="entry name" value="PBP2_transferrin_C"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="CDD" id="cd13618">
    <property type="entry name" value="PBP2_transferrin_N"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="DisProt" id="DP00616"/>
  <dbReference type="Gene3D" id="3.40.190.10">
    <property type="entry name" value="Periplasmic binding protein-like II"/>
    <property type="match status" value="4"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR030684">
    <property type="entry name" value="Lactotransferrin"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR016357">
    <property type="entry name" value="Transferrin"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR001156">
    <property type="entry name" value="Transferrin-like_dom"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR018195">
    <property type="entry name" value="Transferrin_Fe_BS"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR11485:SF55">
    <property type="entry name" value="LACTOTRANSFERRIN"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR11485">
    <property type="entry name" value="TRANSFERRIN"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF00405">
    <property type="entry name" value="Transferrin"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="PIRSF" id="PIRSF500683">
    <property type="entry name" value="Lactotransferrin"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PIRSF" id="PIRSF002549">
    <property type="entry name" value="Transferrin"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PRINTS" id="PR00422">
    <property type="entry name" value="TRANSFERRIN"/>
  </dbReference>
  <dbReference type="SMART" id="SM00094">
    <property type="entry name" value="TR_FER"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="SUPFAM" id="SSF53850">
    <property type="entry name" value="Periplasmic binding protein-like II"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS00205">
    <property type="entry name" value="TRANSFERRIN_LIKE_1"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS00206">
    <property type="entry name" value="TRANSFERRIN_LIKE_2"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS00207">
    <property type="entry name" value="TRANSFERRIN_LIKE_3"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS51408">
    <property type="entry name" value="TRANSFERRIN_LIKE_4"/>
    <property type="match status" value="2"/>
  </dbReference>
  <proteinExistence type="evidence at protein level"/>
  <keyword id="KW-0002">3D-structure</keyword>
  <keyword id="KW-0877">Alternative promoter usage</keyword>
  <keyword id="KW-0044">Antibiotic</keyword>
  <keyword id="KW-0929">Antimicrobial</keyword>
  <keyword id="KW-0963">Cytoplasm</keyword>
  <keyword id="KW-0903">Direct protein sequencing</keyword>
  <keyword id="KW-1015">Disulfide bond</keyword>
  <keyword id="KW-0238">DNA-binding</keyword>
  <keyword id="KW-0325">Glycoprotein</keyword>
  <keyword id="KW-0358">Heparin-binding</keyword>
  <keyword id="KW-0378">Hydrolase</keyword>
  <keyword id="KW-0391">Immunity</keyword>
  <keyword id="KW-0406">Ion transport</keyword>
  <keyword id="KW-0408">Iron</keyword>
  <keyword id="KW-0410">Iron transport</keyword>
  <keyword id="KW-1017">Isopeptide bond</keyword>
  <keyword id="KW-0479">Metal-binding</keyword>
  <keyword id="KW-0539">Nucleus</keyword>
  <keyword id="KW-0892">Osteogenesis</keyword>
  <keyword id="KW-0645">Protease</keyword>
  <keyword id="KW-1185">Reference proteome</keyword>
  <keyword id="KW-0677">Repeat</keyword>
  <keyword id="KW-0964">Secreted</keyword>
  <keyword id="KW-0720">Serine protease</keyword>
  <keyword id="KW-0732">Signal</keyword>
  <keyword id="KW-0804">Transcription</keyword>
  <keyword id="KW-0805">Transcription regulation</keyword>
  <keyword id="KW-0813">Transport</keyword>
  <keyword id="KW-0832">Ubl conjugation</keyword>
  <feature type="signal peptide" evidence="15">
    <location>
      <begin position="1"/>
      <end position="19"/>
    </location>
  </feature>
  <feature type="chain" id="PRO_0000035732" description="Lactotransferrin">
    <location>
      <begin position="20"/>
      <end position="710"/>
    </location>
  </feature>
  <feature type="peptide" id="PRO_0000422770" description="Lactoferricin-H">
    <location>
      <begin position="20"/>
      <end position="67"/>
    </location>
  </feature>
  <feature type="peptide" id="PRO_0000035733" description="Kaliocin-1">
    <location>
      <begin position="171"/>
      <end position="201"/>
    </location>
  </feature>
  <feature type="peptide" id="PRO_0000035734" description="Lactoferroxin-A">
    <location>
      <begin position="338"/>
      <end position="343"/>
    </location>
  </feature>
  <feature type="peptide" id="PRO_0000035735" description="Lactoferroxin-B">
    <location>
      <begin position="543"/>
      <end position="547"/>
    </location>
  </feature>
  <feature type="peptide" id="PRO_0000035736" description="Lactoferroxin-C">
    <location>
      <begin position="680"/>
      <end position="686"/>
    </location>
  </feature>
  <feature type="domain" description="Transferrin-like 1" evidence="1">
    <location>
      <begin position="25"/>
      <end position="352"/>
    </location>
  </feature>
  <feature type="domain" description="Transferrin-like 2" evidence="1">
    <location>
      <begin position="364"/>
      <end position="695"/>
    </location>
  </feature>
  <feature type="region of interest" description="Bactericidal and antifungal activity">
    <location>
      <begin position="20"/>
      <end position="29"/>
    </location>
  </feature>
  <feature type="region of interest" description="Critical for glycosaminoglycan, lipid A, lysozyme and DNA binding">
    <location>
      <begin position="20"/>
      <end position="24"/>
    </location>
  </feature>
  <feature type="region of interest" description="Important for full bactericidal and antifungal activities">
    <location>
      <begin position="21"/>
      <end position="22"/>
    </location>
  </feature>
  <feature type="region of interest" description="Bactericidal and antifungal activity">
    <location>
      <begin position="39"/>
      <end position="49"/>
    </location>
  </feature>
  <feature type="region of interest" description="Interaction with lipopolysaccharide">
    <location>
      <begin position="39"/>
      <end position="49"/>
    </location>
  </feature>
  <feature type="region of interest" description="Interaction with PspA">
    <location>
      <begin position="39"/>
      <end position="46"/>
    </location>
  </feature>
  <feature type="region of interest" description="Involved in glycosaminoglycan binding">
    <location>
      <begin position="46"/>
      <end position="51"/>
    </location>
  </feature>
  <feature type="region of interest" description="Interaction with PspA">
    <location>
      <begin position="57"/>
      <end position="58"/>
    </location>
  </feature>
  <feature type="active site" evidence="68">
    <location>
      <position position="92"/>
    </location>
  </feature>
  <feature type="active site" description="Nucleophile" evidence="68">
    <location>
      <position position="278"/>
    </location>
  </feature>
  <feature type="binding site" evidence="1 2 4 11 20 26 30 39 47 48 49 50 51 60">
    <location>
      <position position="79"/>
    </location>
    <ligand>
      <name>Fe(3+)</name>
      <dbReference type="ChEBI" id="CHEBI:29034"/>
      <label>1</label>
    </ligand>
  </feature>
  <feature type="binding site" evidence="1 2 4 11 20 26 30 39 47 48 49 50 51 60">
    <location>
      <position position="111"/>
    </location>
    <ligand>
      <name>Fe(3+)</name>
      <dbReference type="ChEBI" id="CHEBI:29034"/>
      <label>1</label>
    </ligand>
  </feature>
  <feature type="binding site" evidence="1 2 4 6 11 20 23 26 30 39 47 48 50 51 60">
    <location>
      <position position="136"/>
    </location>
    <ligand>
      <name>hydrogencarbonate</name>
      <dbReference type="ChEBI" id="CHEBI:17544"/>
      <label>1</label>
    </ligand>
  </feature>
  <feature type="binding site" evidence="1 2 4 6 11 20 23 26 30 39 47 48 50 51 60">
    <location>
      <position position="140"/>
    </location>
    <ligand>
      <name>hydrogencarbonate</name>
      <dbReference type="ChEBI" id="CHEBI:17544"/>
      <label>1</label>
    </ligand>
  </feature>
  <feature type="binding site" evidence="1 2 4 6 11 20 23 26 30 39 47 48 50 51 60">
    <location>
      <position position="142"/>
    </location>
    <ligand>
      <name>hydrogencarbonate</name>
      <dbReference type="ChEBI" id="CHEBI:17544"/>
      <label>1</label>
    </ligand>
  </feature>
  <feature type="binding site" evidence="1 2 4 6 11 20 23 26 30 39 47 48 50 51 60">
    <location>
      <position position="143"/>
    </location>
    <ligand>
      <name>hydrogencarbonate</name>
      <dbReference type="ChEBI" id="CHEBI:17544"/>
      <label>1</label>
    </ligand>
  </feature>
  <feature type="binding site" evidence="1 2 4 11 20 26 30 39 47 48 49 50 51 60">
    <location>
      <position position="211"/>
    </location>
    <ligand>
      <name>Fe(3+)</name>
      <dbReference type="ChEBI" id="CHEBI:29034"/>
      <label>1</label>
    </ligand>
  </feature>
  <feature type="binding site" evidence="1 2 4 11 20 26 30 39 47 48 49 50 51 60">
    <location>
      <position position="272"/>
    </location>
    <ligand>
      <name>Fe(3+)</name>
      <dbReference type="ChEBI" id="CHEBI:29034"/>
      <label>1</label>
    </ligand>
  </feature>
  <feature type="binding site" evidence="1 2 4 11 20 26 30 39 47 48 49 50 51 60">
    <location>
      <position position="414"/>
    </location>
    <ligand>
      <name>Fe(3+)</name>
      <dbReference type="ChEBI" id="CHEBI:29034"/>
      <label>2</label>
    </ligand>
  </feature>
  <feature type="binding site" evidence="1 2 4 11 20 26 30 39 47 48 49 50 51 60">
    <location>
      <position position="454"/>
    </location>
    <ligand>
      <name>Fe(3+)</name>
      <dbReference type="ChEBI" id="CHEBI:29034"/>
      <label>2</label>
    </ligand>
  </feature>
  <feature type="binding site" evidence="1 2 4 6 11 20 23 26 30 39 47 48 50 51 60">
    <location>
      <position position="480"/>
    </location>
    <ligand>
      <name>hydrogencarbonate</name>
      <dbReference type="ChEBI" id="CHEBI:17544"/>
      <label>2</label>
    </ligand>
  </feature>
  <feature type="binding site" evidence="1 2 4 6 11 20 23 26 30 39 47 48 50 51 60">
    <location>
      <position position="484"/>
    </location>
    <ligand>
      <name>hydrogencarbonate</name>
      <dbReference type="ChEBI" id="CHEBI:17544"/>
      <label>2</label>
    </ligand>
  </feature>
  <feature type="binding site" evidence="1 2 4 6 11 20 23 26 30 39 47 48 50 51 60">
    <location>
      <position position="486"/>
    </location>
    <ligand>
      <name>hydrogencarbonate</name>
      <dbReference type="ChEBI" id="CHEBI:17544"/>
      <label>2</label>
    </ligand>
  </feature>
  <feature type="binding site" evidence="1 2 4 6 11 20 23 26 30 39 47 48 50 51 60">
    <location>
      <position position="487"/>
    </location>
    <ligand>
      <name>hydrogencarbonate</name>
      <dbReference type="ChEBI" id="CHEBI:17544"/>
      <label>2</label>
    </ligand>
  </feature>
  <feature type="binding site" evidence="1 2 4 11 20 26 30 39 47 48 49 50 51 60">
    <location>
      <position position="547"/>
    </location>
    <ligand>
      <name>Fe(3+)</name>
      <dbReference type="ChEBI" id="CHEBI:29034"/>
      <label>2</label>
    </ligand>
  </feature>
  <feature type="binding site" evidence="1 2 4 11 20 26 30 39 47 48 49 50 51 60">
    <location>
      <position position="616"/>
    </location>
    <ligand>
      <name>Fe(3+)</name>
      <dbReference type="ChEBI" id="CHEBI:29034"/>
      <label>2</label>
    </ligand>
  </feature>
  <feature type="site" description="Interaction with PspA">
    <location>
      <position position="23"/>
    </location>
  </feature>
  <feature type="site" description="Interaction with PspA">
    <location>
      <position position="32"/>
    </location>
  </feature>
  <feature type="site" description="Important for iron binding">
    <location>
      <position position="229"/>
    </location>
  </feature>
  <feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="19 20 23 26 32 46 60">
    <location>
      <position position="156"/>
    </location>
  </feature>
  <feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="20 23 26 32 34 60">
    <location>
      <position position="497"/>
    </location>
  </feature>
  <feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="32">
    <location>
      <position position="642"/>
    </location>
  </feature>
  <feature type="disulfide bond">
    <location>
      <begin position="28"/>
      <end position="64"/>
    </location>
  </feature>
  <feature type="disulfide bond">
    <location>
      <begin position="38"/>
      <end position="55"/>
    </location>
  </feature>
  <feature type="disulfide bond">
    <location>
      <begin position="134"/>
      <end position="217"/>
    </location>
  </feature>
  <feature type="disulfide bond">
    <location>
      <begin position="176"/>
      <end position="192"/>
    </location>
  </feature>
  <feature type="disulfide bond">
    <location>
      <begin position="189"/>
      <end position="200"/>
    </location>
  </feature>
  <feature type="disulfide bond">
    <location>
      <begin position="250"/>
      <end position="264"/>
    </location>
  </feature>
  <feature type="disulfide bond">
    <location>
      <begin position="367"/>
      <end position="399"/>
    </location>
  </feature>
  <feature type="disulfide bond">
    <location>
      <begin position="377"/>
      <end position="390"/>
    </location>
  </feature>
  <feature type="disulfide bond">
    <location>
      <begin position="424"/>
      <end position="705"/>
    </location>
  </feature>
  <feature type="disulfide bond">
    <location>
      <begin position="446"/>
      <end position="668"/>
    </location>
  </feature>
  <feature type="disulfide bond">
    <location>
      <begin position="478"/>
      <end position="553"/>
    </location>
  </feature>
  <feature type="disulfide bond">
    <location>
      <begin position="502"/>
      <end position="696"/>
    </location>
  </feature>
  <feature type="disulfide bond">
    <location>
      <begin position="512"/>
      <end position="526"/>
    </location>
  </feature>
  <feature type="disulfide bond">
    <location>
      <begin position="523"/>
      <end position="536"/>
    </location>
  </feature>
  <feature type="disulfide bond">
    <location>
      <begin position="594"/>
      <end position="608"/>
    </location>
  </feature>
  <feature type="disulfide bond">
    <location>
      <begin position="646"/>
      <end position="651"/>
    </location>
  </feature>
  <feature type="splice variant" id="VSP_044308" description="In isoform DeltaLf." evidence="65 66">
    <location>
      <begin position="1"/>
      <end position="44"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_069298" description="Associated with lower plasma lactoferrin concentrations; dbSNP:rs10662431." evidence="8 15 16 21 38 39 40 41 55 56 57 58 63 64">
    <original>R</original>
    <variation>RR</variation>
    <location>
      <position position="22"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_013504" description="In dbSNP:rs1126477." evidence="8 15 39 54 56 63 64">
    <original>A</original>
    <variation>T</variation>
    <location>
      <position position="29"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_013505" description="Decreased antibacterial activity against Gram-positive bacteria; seems to reduce susceptibility to localized juvenile periodontitis; associated with increased plasma lactoferrin concentrations and possibly with susceptibility to coronary artery stenosis; dbSNP:rs1126478." evidence="8 15 38 39 54 56 63 64">
    <original>K</original>
    <variation>R</variation>
    <location>
      <position position="47"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_013506" description="In dbSNP:rs1126479." evidence="41">
    <original>I</original>
    <variation>T</variation>
    <location>
      <position position="148"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_013507" description="In dbSNP:rs1042055." evidence="41 55">
    <original>G</original>
    <variation>C</variation>
    <location>
      <position position="422"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_013508" description="In dbSNP:rs2073495." evidence="8 26 39 42 59 64">
    <original>E</original>
    <variation>D</variation>
    <location>
      <position position="579"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolishes binding to heparin, lipid A, lysozyme and DNA." evidence="53">
    <location>
      <begin position="20"/>
      <end position="23"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Greatly impairs binding to heparin, lipid A, lysozyme and DNA. Impairs antibacterial activity." evidence="7">
    <location>
      <begin position="20"/>
      <end position="22"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Impairs binding to heparin, lipid A, lysozyme and DNA.">
    <location>
      <begin position="20"/>
      <end position="21"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Impairs iron binding and changes domain closure." evidence="48">
    <original>D</original>
    <variation>S</variation>
    <location>
      <position position="79"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Almost no protease activity." evidence="12">
    <original>K</original>
    <variation>A</variation>
    <location>
      <position position="92"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Disrupts anion binding site and destabilizes iron binding." evidence="9 50">
    <original>R</original>
    <variation>D</variation>
    <variation>E</variation>
    <variation>S</variation>
    <location>
      <position position="140"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Destabilizes iron binding slightly." evidence="4 11">
    <original>R</original>
    <variation>G</variation>
    <variation>E</variation>
    <location>
      <position position="229"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Destabilizes iron binding significantly." evidence="4 11">
    <original>R</original>
    <variation>K</variation>
    <variation>L</variation>
    <location>
      <position position="229"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="No effect." evidence="12">
    <original>P</original>
    <variation>V</variation>
    <location>
      <position position="270"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Destabilizes iron binding." evidence="51">
    <original>H</original>
    <variation>A</variation>
    <variation>C</variation>
    <variation>G</variation>
    <variation>E</variation>
    <variation>F</variation>
    <variation>L</variation>
    <variation>M</variation>
    <variation>P</variation>
    <variation>Q</variation>
    <variation>T</variation>
    <variation>Y</variation>
    <location>
      <position position="272"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="No protease activity." evidence="12">
    <original>S</original>
    <variation>A</variation>
    <location>
      <position position="278"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 17; AAA58656." evidence="67" ref="17">
    <original>L</original>
    <variation>P</variation>
    <location>
      <position position="14"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 14; AAH15822/AAH15823." evidence="67" ref="14">
    <original>R</original>
    <variation>S</variation>
    <location>
      <position position="21"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 22; AA sequence." evidence="67" ref="22">
    <original>T</original>
    <variation>D</variation>
    <location>
      <position position="36"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 14; AAH22347." evidence="67" ref="14">
    <original>R</original>
    <variation>C</variation>
    <location>
      <position position="49"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 14; AAH15823." evidence="67" ref="14">
    <original>G</original>
    <variation>C</variation>
    <location>
      <position position="130"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 14; AAH22347." evidence="67" ref="14">
    <original>L</original>
    <variation>R</variation>
    <location>
      <position position="138"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 18; AA sequence." evidence="67" ref="18">
    <location>
      <position position="140"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 18; AA sequence." evidence="67" ref="18">
    <location>
      <position position="169"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 18; AA sequence." evidence="67" ref="18">
    <original>DA</original>
    <variation>NASVLMDSEGGFLAR</variation>
    <location>
      <begin position="409"/>
      <end position="410"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 17; AAA59511." evidence="67" ref="17">
    <original>G</original>
    <variation>E</variation>
    <location>
      <position position="415"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 17; AAA58656." evidence="67" ref="17">
    <original>A</original>
    <variation>G</variation>
    <location>
      <position position="431"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 14; AAH15822/AAH15823." evidence="67" ref="14">
    <original>A</original>
    <variation>T</variation>
    <location>
      <position position="456"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 26; AAA86665." evidence="67" ref="26">
    <original>G</original>
    <variation>A</variation>
    <location>
      <position position="487"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 18; AA sequence." evidence="67" ref="18">
    <original>Q</original>
    <variation>E</variation>
    <location>
      <position position="531"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 14; AAH15822." evidence="67" ref="14">
    <original>V</original>
    <variation>E</variation>
    <location>
      <position position="537"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 18; AA sequence and 27; AA sequence." evidence="67" ref="18 27">
    <original>K</original>
    <variation>R</variation>
    <location>
      <position position="694"/>
    </location>
  </feature>
  <feature type="strand" evidence="71">
    <location>
      <begin position="24"/>
      <end position="31"/>
    </location>
  </feature>
  <feature type="helix" evidence="71">
    <location>
      <begin position="32"/>
      <end position="47"/>
    </location>
  </feature>
  <feature type="strand" evidence="77">
    <location>
      <begin position="50"/>
      <end position="52"/>
    </location>
  </feature>
  <feature type="strand" evidence="71">
    <location>
      <begin position="53"/>
      <end position="57"/>
    </location>
  </feature>
  <feature type="helix" evidence="71">
    <location>
      <begin position="61"/>
      <end position="69"/>
    </location>
  </feature>
  <feature type="strand" evidence="71">
    <location>
      <begin position="75"/>
      <end position="78"/>
    </location>
  </feature>
  <feature type="helix" evidence="71">
    <location>
      <begin position="80"/>
      <end position="87"/>
    </location>
  </feature>
  <feature type="turn" evidence="71">
    <location>
      <begin position="89"/>
      <end position="91"/>
    </location>
  </feature>
  <feature type="strand" evidence="71">
    <location>
      <begin position="93"/>
      <end position="102"/>
    </location>
  </feature>
  <feature type="strand" evidence="71">
    <location>
      <begin position="104"/>
      <end position="118"/>
    </location>
  </feature>
  <feature type="strand" evidence="75">
    <location>
      <begin position="119"/>
      <end position="121"/>
    </location>
  </feature>
  <feature type="helix" evidence="71">
    <location>
      <begin position="125"/>
      <end position="127"/>
    </location>
  </feature>
  <feature type="strand" evidence="71">
    <location>
      <begin position="132"/>
      <end position="136"/>
    </location>
  </feature>
  <feature type="turn" evidence="71">
    <location>
      <begin position="141"/>
      <end position="144"/>
    </location>
  </feature>
  <feature type="helix" evidence="71">
    <location>
      <begin position="145"/>
      <end position="151"/>
    </location>
  </feature>
  <feature type="helix" evidence="71">
    <location>
      <begin position="152"/>
      <end position="154"/>
    </location>
  </feature>
  <feature type="turn" evidence="72">
    <location>
      <begin position="159"/>
      <end position="161"/>
    </location>
  </feature>
  <feature type="helix" evidence="71">
    <location>
      <begin position="164"/>
      <end position="171"/>
    </location>
  </feature>
  <feature type="strand" evidence="71">
    <location>
      <begin position="172"/>
      <end position="176"/>
    </location>
  </feature>
  <feature type="turn" evidence="71">
    <location>
      <begin position="182"/>
      <end position="184"/>
    </location>
  </feature>
  <feature type="helix" evidence="71">
    <location>
      <begin position="186"/>
      <end position="188"/>
    </location>
  </feature>
  <feature type="turn" evidence="71">
    <location>
      <begin position="189"/>
      <end position="191"/>
    </location>
  </feature>
  <feature type="helix" evidence="71">
    <location>
      <begin position="196"/>
      <end position="198"/>
    </location>
  </feature>
  <feature type="strand" evidence="76">
    <location>
      <begin position="206"/>
      <end position="208"/>
    </location>
  </feature>
  <feature type="helix" evidence="71">
    <location>
      <begin position="210"/>
      <end position="219"/>
    </location>
  </feature>
  <feature type="strand" evidence="71">
    <location>
      <begin position="224"/>
      <end position="229"/>
    </location>
  </feature>
  <feature type="helix" evidence="71">
    <location>
      <begin position="232"/>
      <end position="236"/>
    </location>
  </feature>
  <feature type="helix" evidence="71">
    <location>
      <begin position="240"/>
      <end position="243"/>
    </location>
  </feature>
  <feature type="strand" evidence="71">
    <location>
      <begin position="246"/>
      <end position="250"/>
    </location>
  </feature>
  <feature type="turn" evidence="71">
    <location>
      <begin position="251"/>
      <end position="253"/>
    </location>
  </feature>
  <feature type="strand" evidence="71">
    <location>
      <begin position="254"/>
      <end position="257"/>
    </location>
  </feature>
  <feature type="helix" evidence="71">
    <location>
      <begin position="258"/>
      <end position="263"/>
    </location>
  </feature>
  <feature type="strand" evidence="71">
    <location>
      <begin position="266"/>
      <end position="270"/>
    </location>
  </feature>
  <feature type="strand" evidence="71">
    <location>
      <begin position="273"/>
      <end position="280"/>
    </location>
  </feature>
  <feature type="helix" evidence="71">
    <location>
      <begin position="283"/>
      <end position="297"/>
    </location>
  </feature>
  <feature type="turn" evidence="71">
    <location>
      <begin position="299"/>
      <end position="301"/>
    </location>
  </feature>
  <feature type="strand" evidence="78">
    <location>
      <begin position="302"/>
      <end position="304"/>
    </location>
  </feature>
  <feature type="strand" evidence="71">
    <location>
      <begin position="317"/>
      <end position="319"/>
    </location>
  </feature>
  <feature type="strand" evidence="71">
    <location>
      <begin position="325"/>
      <end position="328"/>
    </location>
  </feature>
  <feature type="helix" evidence="71">
    <location>
      <begin position="335"/>
      <end position="339"/>
    </location>
  </feature>
  <feature type="helix" evidence="74">
    <location>
      <begin position="341"/>
      <end position="348"/>
    </location>
  </feature>
  <feature type="helix" evidence="74">
    <location>
      <begin position="349"/>
      <end position="351"/>
    </location>
  </feature>
  <feature type="helix" evidence="70">
    <location>
      <begin position="354"/>
      <end position="362"/>
    </location>
  </feature>
  <feature type="strand" evidence="70">
    <location>
      <begin position="363"/>
      <end position="370"/>
    </location>
  </feature>
  <feature type="helix" evidence="70">
    <location>
      <begin position="371"/>
      <end position="383"/>
    </location>
  </feature>
  <feature type="turn" evidence="70">
    <location>
      <begin position="384"/>
      <end position="386"/>
    </location>
  </feature>
  <feature type="strand" evidence="70">
    <location>
      <begin position="387"/>
      <end position="395"/>
    </location>
  </feature>
  <feature type="helix" evidence="70">
    <location>
      <begin position="396"/>
      <end position="404"/>
    </location>
  </feature>
  <feature type="strand" evidence="70">
    <location>
      <begin position="410"/>
      <end position="413"/>
    </location>
  </feature>
  <feature type="helix" evidence="70">
    <location>
      <begin position="415"/>
      <end position="423"/>
    </location>
  </feature>
  <feature type="strand" evidence="70">
    <location>
      <begin position="427"/>
      <end position="434"/>
    </location>
  </feature>
  <feature type="strand" evidence="70">
    <location>
      <begin position="436"/>
      <end position="439"/>
    </location>
  </feature>
  <feature type="strand" evidence="69">
    <location>
      <begin position="440"/>
      <end position="442"/>
    </location>
  </feature>
  <feature type="helix" evidence="70">
    <location>
      <begin position="446"/>
      <end position="448"/>
    </location>
  </feature>
  <feature type="strand" evidence="70">
    <location>
      <begin position="454"/>
      <end position="463"/>
    </location>
  </feature>
  <feature type="helix" evidence="70">
    <location>
      <begin position="469"/>
      <end position="471"/>
    </location>
  </feature>
  <feature type="strand" evidence="70">
    <location>
      <begin position="475"/>
      <end position="480"/>
    </location>
  </feature>
  <feature type="turn" evidence="70">
    <location>
      <begin position="485"/>
      <end position="488"/>
    </location>
  </feature>
  <feature type="helix" evidence="70">
    <location>
      <begin position="489"/>
      <end position="499"/>
    </location>
  </feature>
  <feature type="helix" evidence="70">
    <location>
      <begin position="504"/>
      <end position="506"/>
    </location>
  </feature>
  <feature type="strand" evidence="70">
    <location>
      <begin position="508"/>
      <end position="512"/>
    </location>
  </feature>
  <feature type="strand" evidence="74">
    <location>
      <begin position="514"/>
      <end position="516"/>
    </location>
  </feature>
  <feature type="helix" evidence="70">
    <location>
      <begin position="521"/>
      <end position="523"/>
    </location>
  </feature>
  <feature type="turn" evidence="73">
    <location>
      <begin position="533"/>
      <end position="536"/>
    </location>
  </feature>
  <feature type="helix" evidence="70">
    <location>
      <begin position="546"/>
      <end position="555"/>
    </location>
  </feature>
  <feature type="strand" evidence="70">
    <location>
      <begin position="560"/>
      <end position="565"/>
    </location>
  </feature>
  <feature type="helix" evidence="70">
    <location>
      <begin position="566"/>
      <end position="570"/>
    </location>
  </feature>
  <feature type="strand" evidence="74">
    <location>
      <begin position="573"/>
      <end position="576"/>
    </location>
  </feature>
  <feature type="helix" evidence="70">
    <location>
      <begin position="580"/>
      <end position="583"/>
    </location>
  </feature>
  <feature type="helix" evidence="70">
    <location>
      <begin position="587"/>
      <end position="589"/>
    </location>
  </feature>
  <feature type="strand" evidence="70">
    <location>
      <begin position="590"/>
      <end position="593"/>
    </location>
  </feature>
  <feature type="strand" evidence="70">
    <location>
      <begin position="599"/>
      <end position="601"/>
    </location>
  </feature>
  <feature type="helix" evidence="70">
    <location>
      <begin position="602"/>
      <end position="607"/>
    </location>
  </feature>
  <feature type="strand" evidence="70">
    <location>
      <begin position="610"/>
      <end position="613"/>
    </location>
  </feature>
  <feature type="strand" evidence="70">
    <location>
      <begin position="617"/>
      <end position="620"/>
    </location>
  </feature>
  <feature type="helix" evidence="70">
    <location>
      <begin position="622"/>
      <end position="624"/>
    </location>
  </feature>
  <feature type="helix" evidence="70">
    <location>
      <begin position="625"/>
      <end position="639"/>
    </location>
  </feature>
  <feature type="strand" evidence="76">
    <location>
      <begin position="640"/>
      <end position="642"/>
    </location>
  </feature>
  <feature type="turn" evidence="70">
    <location>
      <begin position="646"/>
      <end position="649"/>
    </location>
  </feature>
  <feature type="strand" evidence="70">
    <location>
      <begin position="655"/>
      <end position="657"/>
    </location>
  </feature>
  <feature type="strand" evidence="78">
    <location>
      <begin position="659"/>
      <end position="662"/>
    </location>
  </feature>
  <feature type="strand" evidence="70">
    <location>
      <begin position="666"/>
      <end position="670"/>
    </location>
  </feature>
  <feature type="helix" evidence="70">
    <location>
      <begin position="678"/>
      <end position="682"/>
    </location>
  </feature>
  <feature type="helix" evidence="70">
    <location>
      <begin position="684"/>
      <end position="696"/>
    </location>
  </feature>
  <feature type="helix" evidence="70">
    <location>
      <begin position="700"/>
      <end position="709"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine; alternate" evidence="36">
    <location sequence="P02788-2">
      <position position="10"/>
    </location>
  </feature>
  <feature type="glycosylation site" description="O-linked (GlcNAc) serine; alternate" evidence="36">
    <location sequence="P02788-2">
      <position position="10"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="36">
    <location sequence="P02788-2">
      <position position="379"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="36">
    <location sequence="P02788-2">
      <position position="391"/>
    </location>
  </feature>
  <evidence type="ECO:0000255" key="1">
    <source>
      <dbReference type="PROSITE-ProRule" id="PRU00741"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="2">
    <source>
      <dbReference type="PubMed" id="10089347"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="3">
    <source>
      <dbReference type="PubMed" id="10792619"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="4">
    <source>
      <dbReference type="PubMed" id="10828980"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="5">
    <source>
      <dbReference type="PubMed" id="11083624"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="6">
    <source>
      <dbReference type="PubMed" id="11128996"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="7">
    <source>
      <dbReference type="PubMed" id="11179314"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="8">
    <source>
      <dbReference type="PubMed" id="11702692"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="9">
    <source>
      <dbReference type="PubMed" id="12037297"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="10">
    <source>
      <dbReference type="PubMed" id="12037568"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="11">
    <source>
      <dbReference type="PubMed" id="12450380"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="12">
    <source>
      <dbReference type="PubMed" id="12535064"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="13">
    <source>
      <dbReference type="PubMed" id="12693969"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="14">
    <source>
      <dbReference type="PubMed" id="1369293"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="15">
    <source>
      <dbReference type="PubMed" id="14573629"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="16">
    <source>
      <dbReference type="PubMed" id="14702039"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="17">
    <source>
      <dbReference type="PubMed" id="15166119"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="18">
    <source>
      <dbReference type="PubMed" id="15222485"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="19">
    <source>
      <dbReference type="PubMed" id="15299444"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="20">
    <source>
      <dbReference type="PubMed" id="15299793"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="21">
    <source>
      <dbReference type="PubMed" id="15489334"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="22">
    <source>
      <dbReference type="PubMed" id="15687491"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="23">
    <source>
      <dbReference type="PubMed" id="1581307"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="24">
    <source>
      <dbReference type="PubMed" id="1599934"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="25">
    <source>
      <dbReference type="PubMed" id="16048952"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="26">
    <source>
      <dbReference type="PubMed" id="16201406"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="27">
    <source>
      <dbReference type="PubMed" id="16842782"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="28">
    <source>
      <dbReference type="PubMed" id="17079302"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="29">
    <source>
      <dbReference type="PubMed" id="17481742"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="30">
    <source>
      <dbReference type="PubMed" id="17543335"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="31">
    <source>
      <dbReference type="PubMed" id="17567961"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="32">
    <source>
      <dbReference type="PubMed" id="18780401"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="33">
    <source>
      <dbReference type="PubMed" id="19033648"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="34">
    <source>
      <dbReference type="PubMed" id="19159218"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="35">
    <source>
      <dbReference type="PubMed" id="20345905"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="36">
    <source>
      <dbReference type="PubMed" id="20404350"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="37">
    <source>
      <dbReference type="PubMed" id="22320386"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="38">
    <source>
      <dbReference type="PubMed" id="22406253"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="39">
    <source>
      <dbReference type="PubMed" id="22900286"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="40">
    <source>
      <dbReference type="PubMed" id="2374734"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="41">
    <source>
      <dbReference type="PubMed" id="2402455"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="42">
    <source>
      <dbReference type="PubMed" id="25946035"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="43">
    <source>
      <dbReference type="PubMed" id="2981589"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="44">
    <source>
      <dbReference type="PubMed" id="3169987"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="45">
    <source>
      <dbReference type="PubMed" id="6802759"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="46">
    <source>
      <dbReference type="PubMed" id="8069634"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="47">
    <source>
      <dbReference type="PubMed" id="8371268"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="48">
    <source>
      <dbReference type="PubMed" id="8594202"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="49">
    <source>
      <dbReference type="PubMed" id="8703903"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="50">
    <source>
      <dbReference type="PubMed" id="8931543"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="51">
    <source>
      <dbReference type="PubMed" id="9003186"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="52">
    <source>
      <dbReference type="PubMed" id="9122171"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="53">
    <source>
      <dbReference type="PubMed" id="9359845"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="54">
    <source>
      <dbReference type="PubMed" id="9873069"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="55">
    <source ref="10"/>
  </evidence>
  <evidence type="ECO:0000269" key="56">
    <source ref="11"/>
  </evidence>
  <evidence type="ECO:0000269" key="57">
    <source ref="17"/>
  </evidence>
  <evidence type="ECO:0000269" key="58">
    <source ref="2"/>
  </evidence>
  <evidence type="ECO:0000269" key="59">
    <source ref="25"/>
  </evidence>
  <evidence type="ECO:0000269" key="60">
    <source ref="71"/>
  </evidence>
  <evidence type="ECO:0000269" key="61">
    <source ref="74"/>
  </evidence>
  <evidence type="ECO:0000269" key="62">
    <source ref="75"/>
  </evidence>
  <evidence type="ECO:0000269" key="63">
    <source ref="8"/>
  </evidence>
  <evidence type="ECO:0000269" key="64">
    <source ref="9"/>
  </evidence>
  <evidence type="ECO:0000303" key="65">
    <source>
      <dbReference type="PubMed" id="14702039"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="66">
    <source>
      <dbReference type="PubMed" id="9122171"/>
    </source>
  </evidence>
  <evidence type="ECO:0000305" key="67"/>
  <evidence type="ECO:0000305" key="68">
    <source>
      <dbReference type="PubMed" id="12535064"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="69">
    <source>
      <dbReference type="PDB" id="1B0L"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="70">
    <source>
      <dbReference type="PDB" id="1CB6"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="71">
    <source>
      <dbReference type="PDB" id="1H45"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="72">
    <source>
      <dbReference type="PDB" id="1LCT"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="73">
    <source>
      <dbReference type="PDB" id="1LFH"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="74">
    <source>
      <dbReference type="PDB" id="1LFI"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="75">
    <source>
      <dbReference type="PDB" id="1LGB"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="76">
    <source>
      <dbReference type="PDB" id="1N76"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="77">
    <source>
      <dbReference type="PDB" id="1Z6W"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="78">
    <source>
      <dbReference type="PDB" id="7JRD"/>
    </source>
  </evidence>
  <sequence length="710" mass="78182" checksum="0489CABA6D13C098" modified="2006-01-24" version="6" precursor="true">MKLVFLVLLFLGALGLCLAGRRRSVQWCAVSQPEATKCFQWQRNMRKVRGPPVSCIKRDSPIQCIQAIAENRADAVTLDGGFIYEAGLAPYKLRPVAAEVYGTERQPRTHYYAVAVVKKGGSFQLNELQGLKSCHTGLRRTAGWNVPIGTLRPFLNWTGPPEPIEAAVARFFSASCVPGADKGQFPNLCRLCAGTGENKCAFSSQEPYFSYSGAFKCLRDGAGDVAFIRESTVFEDLSDEAERDEYELLCPDNTRKPVDKFKDCHLARVPSHAVVARSVNGKEDAIWNLLRQAQEKFGKDKSPKFQLFGSPSGQKDLLFKDSAIGFSRVPPRIDSGLYLGSGYFTAIQNLRKSEEEVAARRARVVWCAVGEQELRKCNQWSGLSEGSVTCSSASTTEDCIALVLKGEADAMSLDGGYVYTAGKCGLVPVLAENYKSQQSSDPDPNCVDRPVEGYLAVAVVRRSDTSLTWNSVKGKKSCHTAVDRTAGWNIPMGLLFNQTGSCKFDEYFSQSCAPGSDPRSNLCALCIGDEQGENKCVPNSNERYYGYTGAFRCLAENAGDVAFVKDVTVLQNTDGNNNEAWAKDLKLADFALLCLDGKRKPVTEARSCHLAMAPNHAVVSRMDKVERLKQVLLHQQAKFGRNGSDCPDKFCLFQSETKNLLFNDNTECLARLHGKTTYEKYLGPQYVAGITNLKKCSTSPLLEACEFLRK</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>